Pasar al contenido principal

NEUROLIPIDOMICA DEL ENVEJECIMIENTO CEREBRAL HUMANO

RTI2018-099200-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE LLEIDA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 88
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Lipidomic signature of stroke recurrence after transient ischemic attack

  • Purroy, Francisco
  • Ois Santiago, Angel Javier
  • Jové, Mariona
  • Arque, Gloria
  • Sol, Joaquim
  • Mauri Capdevila, Gerard
  • Rodríguez-Campello, Ana
  • Pamplona, Reinald
  • Portero Otín, Manuel
  • Roquer, Jaume
While TIA patients have transient symptoms, they should not be underestimated, as they could have an underlying pathology that may lead to a subsequent stroke: stroke recurrence (SR). Previously, it has been described the involvement of lipids in different vascular diseases. The aim of the current study was to perform a lipidomic analysis to identify differences in the lipidomic profile between patients with SR and patients without. Untargeted lipidomic analysis was performed in plasma samples of 460 consecutive TIA patients recruited < 24 h after the onset of symptoms. 37 (8%) patients suffered SR at 90 days. Lipidomic profiling disclosed 7 lipid species differentially expressed between groups: 5 triacylglycerides (TG), 1 diacylglyceride (DG), and 1 alkenyl-PE (plasmalogen) [specifically, TG(56:1), TG(63:0), TG(58:2), TG(50:5), TG(53:7, DG(38:5)) and PE(P-18:0/18:2)]. 6 of these 7 lipid species belonged to the glycerolipid family and a plasmalogen, pointing to bioenergetics pathways, as well as oxidative stress response. In this context, it was proposed the PE(P-18:0/18:2) as potential biomarker of SR condition.The observed changes in lipid patterns suggest pathophysiological mechanisms associated with lipid droplets metabolism and antioxidant protection that is translated to plasma level as consequence of a more intensive or high-risk ischemic condition related to SR., This study was supported by the Government of Catalonia-Agència de Gestió d'Ajuts Universitaris i de Recerca (FP: 2017SGR1628 and 2021SGR01479; RP: 2021SGR00990); Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF, "Investing in your future" and "A way to build Europe") (FP: PI17-01725, PI14/01574; M.P-O: PI 17-00134, 20-0155); the Spanish Ministry of Science, Innovation and Universities (RP: RTI2018-099200-B-I00 and PID2022-143140OB-I00); the Department of Health (RP: SLT002/16/00250); and the INVICTUS plus Research Network (Carlos III Health Institute) (FP, CT and GA: RD16-0019-0017; TS: RD16-0019-0012; AO and JR: RD16-0019-0012; AC: RD16-0019-0006. M.J. is a professor under the Serra Hunter program (Generalitat de Catalunya).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Caudovirales bacteriophages are associated with improved executive function and memory in flies, mice, and humans

  • Mayneris Perxachs, Jordi
  • Castells-Nobau, Anna
  • Arnoriaga Rodríguez, María
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafel
  • Martínez Hernández, Francisco
  • Burokas, Aurelijus, 1982-
  • Coll, Clàudia
  • Moreno-Navarrete, José Maria
  • Zapata-Tona, Cristina
  • Pedraza, Salvador
  • Pérez Brocal, Vicente
  • Ramió-Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Martínez García, Manuel
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
Growing evidence implicates the gut microbiome in cognition. Viruses, the most abundant life entities on the planet, are a commonly overlooked component of the gut virome, dominated by the Caudovirales and Microviridae bacteriophages. Here, we show in a discovery (n = 114) and a validation cohort (n = 942) that subjects with increased Caudovirales and Siphoviridae levels in the gut microbiome had better performance in executive processes and verbal memory. Conversely, increased Microviridae levels were linked to a greater impairment in executive abilities. Microbiota transplantation from human donors with increased specific Caudovirales (>90% from the Siphoviridae family) levels led to increased scores in the novel object recognition test in mice and up-regulated memory-promoting immediate early genes in the prefrontal cortex. Supplementation of the Drosophila diet with the 936 group of lactococcal Siphoviridae bacteriophages resulted in increased memory scores and upregulation of memory-involved brain genes. Thus, bacteriophages warrant consideration as novel actors in the microbiome-brain axis., This work was partially funded by the Instituto de Salud Carlos III (Madrid, Spain) through the project PI15/01934, PI18/01022, PI21/01361) to J.M.F.-R. and the project PI20/01090 (co-funded by the European Regional Development Fund . “A way to make Europe”) to J.M.-P., the grants SAF2015-65878-R from the Ministry of Economy and Competitiveness , Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by the Fondo Europeo de Desarrollo Regional (FEDER) funds, European Commission (FP7, NeuroPain #2013- 602891 ), the Catalan Government (AGAUR, #SGR2017-669 , #2017 SGR- 734, ICREA Academia Award 2015 to R.M. and ICREA Academia Award 2022 to J.M.F.R.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020 ), the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT), and the Project ThinkGut (EFA345/19) 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). CIBERobn is also co-funded by the European Regional Development Fund. We also acknowledge the funding from the Spanish Ministry of Science, Innovation and Universities ( RTI2018-099200-B-I00 ), and the Generalitat of Catalonia (Agency for Management of University and Research grants ( 2017SGR696 ) and Department of Health (SLT002/16/00250)) to R.M M.A.-R. is funded by the Instituto de Salud Carlos III , Río Hortega ( CM19/00190 ). J.M.-P. is funded by the Miguel Servet Program from the Instituto de Salud Carlos III ( ISCIII CP18/00009 ), co-funded by the European Social Fund “Investing in your future.” A.C.-N. is funded by the Instituto de Salud Carlos III , Sara Borrell. MMG was funded by the Spanish Ministry of Science, Innovation and Universities RTI2018-094248-B-I00.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Microbiota alterations in proline metabolism impact depression

  • Mayneris Perxachs, Jordi
  • Martin, Miquel
  • Burokas, Aurelijus, 1982-
  • Escrichs, Anira
  • Deco, Gustavo
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with low treatment efficacy. However, the field is dominated by underpowered studies focusing on major depression not addressing microbiome functionality, compositional nature, or confounding factors. We applied a multi-omics approach combining pre-clinical models with three human cohorts including patients with mild depression. Microbial functions and metabolites converging onto glutamate/GABA metabolism, particularly proline, were linked to depression. High proline consumption was the dietary factor with the strongest impact on depression. Whole-brain dynamics revealed rich club network disruptions associated with depression and circulating proline. Proline supplementation in mice exacerbated depression along with microbial translocation. Human microbiota transplantation induced an emotionally impaired phenotype in mice and alterations in GABA-, proline-, and extracellular matrix-related prefrontal cortex genes. RNAi-mediated knockdown of proline and GABA transporters in Drosophila and mono-association with L. plantarum, a high GABA producer, conferred protection against depression-like states. Targeting the microbiome and dietary proline may open new windows for efficient depression treatment., This work was partially supported by Instituto de Salud Carlos III (Madrid, Spain) through the research grants PI15/01934, PI18/01022, and PI21/01361 to J.M.F.-R. and PI20/01090 (co-funded by the European Regional Development Fund. “A way to make Europe”) to J.M.-P.; the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R.; the Spanish Ministry of Science, Innovation and Universities (PID2019-105969GB-I00); Generalitat Valenciana (Prometeo/2018/133), Spain; and Fondo Europeo de Desarrollo Regional (FEDER) funds to A.M. This work was also supported by the European Commission (FP7, NeuroPain #2013-602891); the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020) to R.M.; the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) to R.M.; Ministry of Science and Innovation and State Research Agency (#PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033) to R.M.; the European Regional Development Fund (project no. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and the Project ThinkGut (EFA345/19), 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra program (POCTEFA, 2014–2020). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00) and the Generalitat of Catalonia (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [SLT002/16/00250]) to R.P. M.A.-R. is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). J.M.-P. is funded by a Miguel Servet contract (CP18/00009) from the Instituto de Salud Carlos III. J.S. is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. M.J. is a professor under “Serra Hunter” program (Generalitat de Catalunya). The graphical abstract was created with BioRender.com. We would like to thank Martijn Eidhof for his help in building the stress treatment machine for Drosophila.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Caudovirales bacteriophages are associated with improved executive function and memory in flies, mice, and humans

  • Mayneris-Perxachs, Jordi
  • Castells-Nobau, Anna
  • Arnoriaga-Rodríguez, María
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Martinez-Hernandez, Francisco
  • Burokas, Aurelijus
  • Coll, Clàudia
  • Moreno-Navarrete, José Maria
  • Zapata-Tona, Cristina
  • Pedraza, Salvador
  • Pérez-Brocal, Vicente
  • Ramió-Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Martinez-Garcia, Manuel
  • Maldonado, Rafael
  • Fernández-Real, José-Manuel
  • Maldonado, Rafael|||/items/37bf5b23-bc7c-4ceb-b309-26d49626d424
  • Martinez-Garcia, Manuel|||/items/8fc0773c-5327-46a0-9cda-e5d2ac19bc69
Growing evidence implicates the gut microbiome in cognition. Viruses, the most abundant life entities on the planet, are a commonly overlooked component of the gut virome, dominated by the Caudovirales and Microviridae bacteriophages. Here, we show in a discovery (n = 114) and a validation cohort (n = 942) that subjects with increased Caudovirales and Siphoviridae levels in the gut microbiome had better performance in executive processes and verbal memory. Conversely, increased Microviridae levels were linked to a greater impairment in executive abilities. Microbiota transplantation from human donors with increased specific Caudovirales (>90% from the Siphoviridae family) levels led to increased scores in the novel object recognition test in mice and up-regulated memory-promoting immediate early genes in the prefrontal cortex. Supplementation of the Drosophila diet with the 936 group of lactococcal Siphoviridae bacteriophages resulted in increased memory scores and upregulation of memory-involved brain genes. Thus, bacteriophages warrant consideration as novel actors in the microbiome-brain axis.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

The Causal Role of Lipoxidative Damage in Mitochondrial Bioenergetic Dysfunction Linked to Alzheimer's Disease Pathology

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Torres Cabestany, Pascual
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Portero Otín, Manuel
  • Ferrer, Isidre
  • Pamplona Gras, Reinald
Current shreds of evidence point to the entorhinal cortex (EC) as the origin of the Alzheimer’s disease (AD) pathology in the cerebrum. Compared with other cortical areas, the neurons from this brain region possess an inherent selective vulnerability derived from particular oxidative stress conditions that favor increased mitochondrial molecular damage with early bioenergetic involvement. This alteration of energy metabolism is the starting point for subsequent changes in a multitude of cell mechanisms, leading to neuronal dysfunction and, ultimately, cell death. These events are induced by changes that come with age, creating the substrate for the alteration of several neuronal pathways that will evolve toward neurodegeneration and, consequently, the development of AD pathology. In this context, the present review will focus on description of the biological mechanisms that confer vulnerability specifically to neurons of the entorhinal cortex, the changes induced by the aging process in this brain region, and the alterations at the mitochondrial level as the earliest mechanism for the development of AD pathology. Current findings allow us to propose the existence of an altered allostatic mechanism at the entorhinal cortex whose core is made up of mitochondrial oxidative stress, lipid metabolism, and energy production, and which, in a positive loop, evolves to neurodegeneration, laying the basis for the onset and progression of AD pathology., Research by the authors was supported by the Institute of Health Carlos III (FIS grantsPI14/00757, PI14/00328, PI20/0155), the Spanish Ministry of Science, Innovation, and Universities(Ministerio de Ciencia, Innovación y Universidades, grant RTI2018-099200-B-I00), and the Generalitatof Catalonia: Agency for Management of University and Research Grants (2017SGR696) to M.P-O.,I.F., and R.P. This study was co-financed by FEDER funds from the European Union (‘A way tobuild Europe’).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

mTOR Complex 1 Content and Regulation Is Adapted to Animal Longevity

  • Mota Martorell, Natàlia
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Decreased content and activity of the mechanistic target of rapamycin (mTOR) signalling pathway, as well as the mTOR complex 1 (mTORC1) itself, are key traits for animal species and human longevity. Since mTORC1 acts as a master regulator of intracellular metabolism, it is respon sible, at least in part, for the longevous phenotype. Conversely, increased content and activity of mTOR signalling and mTORC1 are hallmarks of ageing. Additionally, constitutive and aberrant activity of mTORC1 is also found in age-related diseases such as Alzheimer’s disease (AD) and cancer. The downstream processes regulated through this network are diverse, and depend upon nutrient availability. Hence, multiple nutritional strategies capable of regulating mTORC1 activity and, consequently, delaying the ageing process and the development of age-related diseases, are under continuous study. Among these, the restriction of calories is still the most studied and ro bust intervention capable of downregulating mTOR signalling and feasible for application in the human population., Research by the authors was supported by the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, co-financed by FEDER funds from the European Union ‘A way to build Europe’, grant RTI2018-099200-B-I00), the IRBLleida-Diputació de Lleida (PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696) to R.P. IRBLleida is a CERCA Programme/Generalitat of Catalonia
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Lipidomic signature of stroke recurrence after transient ischemic attack

  • Purroy Garcia, Francisco
  • Ois, Ángel
  • Arque, Gloria
  • Sol, Joaquim
  • Mauri-Capdevila, Gerard
  • Rodríguez-Campello, Ana
  • Pamplona Gras, Reinald
  • Portero Otín, Manuel
  • Roquer, Jaume
While TIA patients have transient symptoms, they should not be underestimated, as they could have an underlying pathology that may lead to a subsequent stroke: stroke recurrence (SR). Previously, it has been described the involvement of lipids in different vascular diseases. The aim of the current study was to perform a lipidomic analysis to identify differences in the lipidomic profile between patients with SR and patients without. Untargeted lipidomic analysis was performed in plasma samples of 460 consecutive TIA patients recruited < 24 h after the onset of symptoms. 37 (8%) patients suffered SR at 90 days. Lipidomic profiling disclosed 7 lipid species differentially expressed between groups: 5 triacylglycerides (TG), 1 diacylglyceride (DG), and 1 alkenyl-PE (plasmalogen) [specifically, TG(56:1), TG(63:0), TG(58:2), TG(50:5), TG(53:7, DG(38:5)) and PE(P-18:0/18:2)]. 6 of these 7 lipid species belonged to the glycerolipid family and a plasmalogen, pointing to bioenergetics pathways, as well as oxidative stress response. In this context, it was proposed the PE(P-18:0/18:2) as potential biomarker of SR condition. The observed changes in lipid patterns suggest pathophysiological mechanisms associated with lipid droplets metabolism and antioxidant protection that is translated to plasma level as consequence of a more intensive or high-risk ischemic condition related to SR., Tis study was supported by the Government of Catalonia-Agència de Gestió d’Ajuts Universitaris i de Recerca (FP: 2017SGR1628 and 2021SGR01479; RP: 2021SGR00990); Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF, "Investing in your future" and "A way to build Europe") (FP: PI17-01725, PI14/01574; M.P-O: PI 17-00134, 20-0155); the Spanish Ministry of Science, Innovation and Universities (RP: RTI2018-099200-B-I00 and PID2022-143140OB-I00); the Department of Health (RP: SLT002/16/00250); and the INVICTUS plus Research Network (Carlos III Health Institute) (FP, CT and GA: RD16-0019-0017; TS: RD16-0019-0012; AO and JR: RD16-0019-0012; AC: RD16-0019-0006. M.J. is a professor under the Serra Hunter program (Generalitat de Catalunya)
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Lipidomic alterations in the cerebral cortex and white matter in sporadic Alzheimer's disease.

  • Obis Monné, Èlia
  • Sol, Joaquim
  • Andrés Benito, Pol
  • Martín Garí, Meritxell
  • Mota Martorell, Natàlia
  • Galo-Licona, José Daniel
  • Piñol Ripoll, Gerard
  • Portero Otín, Manuel
  • Ferrer, Isidro
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Non-targeted LC-MS/MS-based lipidomic analysis was conducted in post-mortem human grey matter frontal cortex area 8 (GM) and white matter of the frontal lobe centrum semi-ovale (WM) to identify lipidome fingerprints in middle-aged individuals with no neurofibrillary tangles and senile plaques, and cases at progressive stages of sporadic Alzheimer's disease (sAD). Complementary data were obtained using RT-qPCR and immunohistochemistry. The results showed that WM presents an adaptive lipid phenotype resistant to lipid peroxidation, characterized by a lower fatty acid unsaturation, peroxidizability index, and higher ether lipid content than the GM. Changes in the lipidomic profile are more marked in the WM than in GM in AD with disease progression. Four functional categories are associated with the different lipid classes affected in sAD: membrane structural composition, bioenergetics, antioxidant protection, and bioactive lipids, with deleterious consequences affecting both neurons and glial cells favoring disease progression., This research was funded by the Spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00, and PID2022-143140OB-I00), the Diputació de Lleida-IRBLleida (PP10605 – PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) to R.P., and Instituto de Salud Carlos III grant (PI20/00155) to M.P.O. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia. Part of the study was also funded by “La Caixa” Foundation under the agreement LCF/PR/HR19/ 52160007: HR18-00452 to I.F. M.J. is a ‘Serra-Hunter’ Fellow. We thank T. Yohannan for editorial help.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Prevalence and Predictors of Cerebral Microangiopathy Determined by Pulsatility Index in an Asymptomatic Population From the ILERVAS Project

  • Purroy Garcia, Francisco
  • Sánchez Peña, Enric
  • Lecube Torelló, Albert
  • Arque, Gloria
  • Vicente-Pascual, Mikel
  • Mauri-Capdevila, Gerard
  • Torreguitart, Núria
  • Hernández García, Marta
  • Barbé Illa, Ferran
  • Fernández i Giráldez, Elvira
  • Pamplona Gras, Reinald
  • Farràs-Sallés, Cristina
  • Mauricio Puente, Dídac
  • Bermúdez López, Marcelino
Background: Little is known about the prevalence of cerebral microangiopathy (CM), which is related to cognitive impairment, in an asymptomatic population. Pulsatility index (PI) is an easily measurable parameter of cerebral vascular resistance in transcranial duplex of the middle cerebral artery (MCA) study. We aimed to determine the prevalence of CM measured by PI of MCA in low to moderate vascular risk subjects. Methods: We included 3,721 subjects between 45 and 70 years without previous history of vascular disease or diabetes mellitus and with at least one other vascular risk factor from the cross-sectional study ILERVAS (Lleida, Spain). Patients underwent transcranial duplex to determine MCA-PI. Possible CM was defined by MCA-PI >1.1. Carotid and femoral arteries ultrasound registration was done to determine the presence, the number, and the area of atheromatous plaques. Body mass index (BMI), pulse pressure (PP) and laboratory data were also recorded. Results: 439 (11.8%) subjects were excluded due to the low quality of transcranial duplex images. Median age was 57 [IQR 52, 62] years. Possible CM was found in 424 (12.9%) subjects. CM patients had higher prevalence of plaques than non-CM (77.4 vs. 66.4%, p < 0.001). PI showed a positive linear correlation with the number of territories with plaques (r = 0.130, p < 0.001), and the total plaque area (r = 0.082, p < 0.001). The predictors of possible CM were the age, male gender, and PP. Conclusions: In low-to-moderate vascular risk asymptomatic population, the proportion of abnormal brain microvascular bed determined by MCA-PI is not negligible. The planned 10-year follow-up will describe the clinical relevance of these findings., This work was supported by grants from the Diputacio de Lleida, Instituto de Salud Carlos III (RETIC RD16/0009/0011) and Ministerio de Ciencia, Inovación y Universidades (IJC2018-037792-I). FP was supported by the Catalan Autonomous Government’s Agència de Gestió d’Ajuts Universitaris i de Recerca (2017 suport a les activitats dels grups de recerca 1628). RP was supported by the Spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696). This study was co-financed by FEDER funds from the European Union (A way to build Europe). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Plasma methionine metabolic profile is associated with longevity in mammals

  • Mota Martorell, Natàlia
  • Jové Font, Mariona
  • Berdún Hernández, Rebeca
  • Pamplona Gras, Reinald
Methionine metabolism arises as a key target to elucidate the molecular adaptations underlying animal longevity due to the negative association between longevity and methionine content. The present study follows a comparative approach to analyse plasma methionine metabolic profile using a LC-MS/MS platform from 11 mammalian species with a longevity ranging from 3.5 to 120 years. Our findings demonstrate the existence of a species-specific plasma profile for methionine metabolism associated with longevity characterised by: i) reduced methionine, cystathionine and choline; ii) increased non-polar amino acids; iii) reduced succinate and malate; and iv) increased carnitine. Our results support the existence of plasma longevity features that might respond to an optimised energetic metabolism and intracellular structures found in long-lived species., This work was supported by the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to R.P. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia. M.J. is a ‘Serra Hunter’ Fellow. N.M.M. received a predoctoral fellowship from the Generalitat of Catalonia (AGAUR, ref 2018FI_B2_00104).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Plasma acylcarnitines and gut-derived aromatic amino acids as sex-specific hub metabolites of the human aging metabolome

  • Sol, Joaquim
  • Obis Monné, Èlia
  • Mota Martorell, Natàlia
  • Pradas Barriga, Irene
  • Galo-Licona, José Daniel
  • Martín Garí, Meritxell
  • Fernández Bernal, Anna
  • Ortega Bravo, Marta
  • Mayneris Perxachs, Jordi
  • Borrás, Consuelo
  • Viña Ribes, José
  • Fuente, Monica de la
  • Mate, Ianire
  • Biarnés, Carles
  • Pedraza, Salvador
  • Vilanova, Joan Carles
  • Brugada, Ramon
  • Ramos, Rafel
  • Serena, Joaquín
  • Ramió Torrentà, Lluís
  • Pineda, Víctor
  • Daunis-i-Estadella, Pepus
  • Thió-Henestrosa, Santiago
  • Barretina Ginesta, Jordi
  • Garre Olmo, Josep
  • Portero Otín, Manuel
  • Fernández Real, José Manuel
  • Puig, Josep
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Aging biology entails a cell/tissue deregulated metabolism that affects all levels of biological organization. Therefore, the application of “omic” techniques that are closer to phenotype, such as metabolomics, to the study of the aging process should be a turning point in the definition of cellular processes involved. The main objective of the present study was to describe the changes in plasma metabolome associated with biological aging and the role of sex in the metabolic regulation during aging. A high-throughput untargeted metabolomic analysis was applied in plasma samples to detect hub metabolites and biomarkers of aging incorporating a sex/gender perspective. A cohort of 1030 healthy human adults (45.9% females, and 54.1% males) from 50 to 98 years of age was used. Results were validated using two independent cohorts (1: n = 146, 53% females, 30–100 years old; 2: n = 68, 70% females, 19–107 years old). Metabolites related to lipid and aromatic amino acid (AAA) metabolisms arose as the main metabolic pathways affected by age, with a high influence of sex. Globally, we describe changes in bioenergetic pathways that point to a decrease in mitochondrial β-oxidation and an accumulation of unsaturated fatty acids and acylcarnitines that could be responsible for the increment of oxidative damage and inflammation characteristic of this physiological process. Furthermore, we describe for the first time the importance of gut-derived AAA catabolites in the aging process describing novel biomarkers that could contribute to better understand this physiological process but also age-related diseases., This research was funded by the Spanish Ministry of Science,Innovation, and Universities (grant RTI2018-099200-B- I00, and PID2022-143140OB-I00, co-funded by the European Regional Development Fund. “A way to build Europe”), and the Generalitat of Catalonia (Agency for Management of University and Research Grants [2021SGR00990] and Department of Health [SLT002/16/00250])to R.P. The work is also supported by “la Caixa” Foundation (Grant Agreement LCF/PR/HR21/52410002) to M.J. IRBLleida is a CERCAProgramme/Generalitat of Catalonia. This work was also partiallysupported by Instituto de Salud Carlos III (Madrid, Spain) through the research grants PI15/01934, PI18/01022, PI20/01090, and PI21/01361 (co-funded by the European Regional Development Fund. “A way to make Europe”), and the Catalan Government (AGAUR,#SGR2017-0734, ICREA Academia Award 2021) to J.M.F-R.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease

  • Dakterzada, Farida
  • Jové Font, Mariona
  • Cantero, José Luís
  • Pamplona Gras, Reinald
Background Oxidative stress is considered to play an important role in the pathogenesis of Alzheimer's disease (AD). It has been observed that oxidative damage to specific protein targets affecting particular functional networks is one of the mechanisms by which oxidative stress contributes to neuronal failure and consequently loss of cognition and AD progression. Studies are lacking in which oxidative damage is measured at both systemic and central fluid levels and in the same cohort of patients. We aimed to determine the levels of both plasma and cerebrospinal fluid (CSF) nonenzymatic protein damage in patients in the continuum of AD and to evaluate the relation of this damage with clinical progression from mild cognitive impairment (MCI) to AD. Methods Different markers of nonenzymatic post-translational protein modification, mostly from oxidative processes, were detected and quantified in plasma and CSF by isotope dilution gas chromatography‒mass spectrometry using selected ion monitoring (SIM-GC/MS) for 289 subjects: 103 AD, 92 MCI, and 94 control subjects. Characteristics of the study population such as age, sex, Mini-mental state examination, CSF AD biomarkers, and APOE ϵ4, were also considered. Results Forty-seven (52.8%) MCI patients progressed to AD during follow-up (58 ± 12.5 months). After controlling for age, sex, and APOE ϵ4 allele, plasma and CSF concentrations of protein damage markers were not associated with either diagnosis of AD or MCI. The CSF levels of nonenzymatic protein damage markers were associated with none of the CSF AD biomarkers. In addition, neither in CSF nor in plasma were the levels of protein damage associated with the MCI to AD progression. Conclusion The lack of association between both CSF and plasma concentrations of nonenzymatic protein damage markers and AD diagnosis and progression suggests that oxidative damage in AD is a pathogenic mechanism specifically expressed at the cell-tissue level, not in extracellular fluids., This research was supported by the Government of Catalonia, Department of Health (PERIS 2019 SLT008/18/00050), and the Agency for the Management of University and Research Grants (2021SGR 00761) to GPR. The spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00 and PID2022-143140OB-I00), the Diputacio ´ de Lleida (PP10605 - PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to RP. The Spanish Ministry of Economy and Competitiveness (PID2020-119978RB-I00), CIBERNED, Alzheimer’s Association (AARG-NTF-22- 924702), the Junta de Andalucía (PY20_00858), and the AndalucíaFEDER Program (UPO-1380913) to JLC. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Succination of protein thiols in human brain aging

  • Jové Font, Mariona
  • Pradas Barriga, Irene
  • Mota Martorell, Natàlia
  • Cabré Cucó, Rosanna
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Ferrer, Isidre
  • Pamplona Gras, Reinald
Human brain evolution toward complexity has been achieved with increasing energy supply as the main adaptation in brain metabolism. Energy metabolism, like other biochemical reactions in aerobic cells, is under enzymatic control and strictly regulated. Nevertheless, physiologically uncontrolled and deleterious reactions take place. It has been proposed that these reactions constitute the basic molecular mechanisms that underlie the maintenance or loss-of-function of neurons and, by extension, cerebral functions during brain aging. In this review article, we focus attention on the role of the nonenzymatic and irreversible adduction of fumarate to the protein thiols, which leads to the formation of S-(2-succino)cysteine (2SC; protein succination) in the human brain. In particular, we first offer a brief approach to the succination reaction, features related to the specificity of protein succination, methods for their detection and quantification, the bases for considering 2SC as a biomarker of mitochondrial stress, the succinated proteome, the cross-regional differences in 2SC content, and changes during brain aging, as well as the potential regulatory significance of fumarate and 2SC. We propose that 2SC defines cross-regional differences of metabolic mitochondrial stress in the human brain and that mitochondrial stress is sustained throughout the healthy adult lifespan in order to preserve neuronal function and survival., Research by the authors was supported by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (FIS grants PI13/00584 and PI14/00328), the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-B-I00), and the Generalitat of Catalonia, Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to RP. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia. IP was supported by a University of Lleida Predoctoral Fellowship. RC and NM-M were supported by a Generalitat of Catalonia Predoctoral Fellowship. MJ is a “Serra Húnter” Fellow.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

The shift in the fatty acid composition of the circulating lipidome in Alzheimer's disease

  • Dakterzada, Farida
  • Jové Font, Mariona
  • Cantero, José Luís
  • Mota Martorell, Natàlia
  • Pamplona Gras, Reinald
  • Piñol Ripoll, Gerard
Introduction: Fatty acids (FAs) are the building blocks of complex lipids and signaling compounds; the role of the lipidome fatty acid profile (LFA) in AD progression remains unclear. Methods: The LFA of plasma and cerebrospinal fluid (CSF) samples from 289 participants (103 AD patients, 92 MCI patients, and 94 controls) was determined by GC-FID. The MCI subjects were followed up for 58 ± 12.5 months. Results: In controls, CSF has a more neuroprotective LFA than plasma. In CSF, a higher content of docosahexaenoic acid was associated with a reduced risk of MCI-to-AD progression. In plasma, higher oleic acid content was associated with lower risk of AD, MCI, and MCI-to-AD progression, whereas higher levels of vaccenic acid and docosahexaenoic acid were associated with greater risk of AD and MCI, and higher rate of MCI-to-AD progression, respectively. Discussion: The circulating LFA is involved in the pathogenesis and progression of AD. Highlights: The lipidome fatty acid profile in CSF and plasma was markedly different. Higher levels of vaccenic acid and lower levels of oleic acid in plasma were associated with greater risk of Alzheimer's disease. In plasma, higher levels of oleic acid were associated with a reduced risk of MCI-to-AD progression. Higher levels of docosahexaenoic acid in CSF were associated with a lower risk of MCI-to-AD progression. Higher levels of docosahexaenoic acid in plasma were associated with a greater rate of MCI-to-AD progression., Government of Catalonia,Grant/Award Number:PERIS 2019 SLT008/18/00050; Ministerio de Ciencia, Innovación y Universidades; European Union ’Awaytobuild Europe’, Grant/Award Numbers: RTI2018-099200-B-I00, PID2023-152233OB-I00; Diputació de Lleida, Grant/Award Number: PP10605-PIRS2021; Spanish Ministry of Economy and Competitiveness, Grant/Award Number: PID2020-119978RB-I00; CIBERNED, Alzheimer’s Association, Grant/Award Number:AARG-NTF-22-924702; Junta de Andalucía, Grant/Award Number: PY20_00858; Andalucía-FEDER Program, Grant/Award Number: UPO-1380913; Agency for Management of University and Research Grants, Grant/Award Number: 2021SGR 00761; Agency for Management of University and Research Grants and the European Social Fund, Grant/Award Number: FI_B100153; Agency for Management of University and Research Grants and the European Social Fund, Grant/Award Number: 2021SGR00990
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Metabolomics reveals that fittest trail runners show a better adaptation of bioenergetic pathways

  • Puigarnau Coma, Sílvia
  • Fernàndez, Anna
  • Obis Monné, Èlia
  • Jové Font, Mariona
  • Castañer Balcells, Marta
  • Pamplona Gras, Reinald
  • Portero Otín, Manuel
  • Camerino Foguet, Oleguer
Objectives: To analyze the effect in the blood metabolome of trail running, a demanding sport that takes place in the natural environment, places considerable strain on both muscles and joints. While metabolic responses to aerobic exercise have been analyzed in-depth, few studies have focused on trail running. Design: Observational study to analyze changes in 35 different metabolites - representative of aerobic exercise- induced by a simulated 21-km trail race with an uphill gradient of 1400 m. Methods: We performed a semiquantitative metabolomics study consisting of capillary blood microsampling and targeted screening with liquid chromatography and mass spectrometry to analyze, in 33 licensed athletes, changes concerning 35 metabolites. Results: We observed significant changes in many metabolites, including increased acetyl-carnitine and taurine concentrations (false discovery rate–corrected paired t-test P value 1.63 × 10–13, and P value 5.021 × 10-12, re- spectively) and decreased carnitine and proline concentrations (P value 6.33 × 10–10, and P value 1.21 × 10–9, re- spectively). Metabolic responses to trail running were largely independent of sex but were influenced by the level of training, with runners with a higher level showing resistance to exercise-induced changes in taurine, 1-methyl histidine, acetyl-carnitine, and hypoxanthine concentrations. Performance (measured as race time) was inversely correlated with changes in specific metabolites (including taurine, serotonin, and hypoxanthine) and directly correlated with increases in glutathione. Conclusions: Our findings demonstrate the usefulness of metabolomics studies for analyzing exercise-induced physiological changes and show individual differences associated with the level of training and performance., This work was supported by the Generalitat de Catalunya, Agency for Management of University and Research Grants [2017SGR696]; by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III [PI17-00134 and PI20-00155]; and by the Spanish Ministry of Science, Innovation and Universities [RTI2018-099200-B-I00]. MJ is a Serra-Hunter program fellow. AF is a fellow of Banco de Santander-UdL predoctoral program. We are also grateful for the support of; the National Institute of Physical Education of Catalonia (INEFC); and the Spanish government subproject Integration ways between qualitative and quantitative data, multiple case development, and synthesis review as main axis for an innovative future in physical activity and sports research [PGC2018-098742-B-C31] (2019–2021) (Ministry of Science, Innovation and Universities/Spanish State Research Agency/European Regional Development Fund), that is part of the coordinated project New approach of research in physical activity and sport from mixed methods perspective (NARPAS_MM) [SPGC201800X098742CV0]; and the Generalitat de Catalunya Research Group [Research group and innovation in designs] (GRID). Technology and multimedia and digital application to observational designs [Grant number 2017 SGR 1405]. FEDER funds are acknowledged [“A way to build Europe”].
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

  • Dakterzada, Farida
  • Benítez, Iván
  • Targa, Adriano
  • Pujol, Montserrat
  • Carnes Vendrell, Anna
  • Jové Font, Mariona
  • Minguez Roure, Olga
  • Vaca, Rafaela
  • Sánchez de la Torre, Manuel
  • Barbé Illa, Ferran
  • Pamplona Gras, Reinald
  • Piñol Ripoll, Gerard
Background Obstructive sleep apnoea (OSA) has a high prevalence in patients with Alzheimer’s disease (AD). Both conditions have been shown to be associated with lipid dysregulation. However, the relationship between OSA severity and alterations in lipid metabolism in the brains of patients with AD has yet to be fully elucidated. In this context, we examined the cerebrospinal fluid (CSF) lipidome of patients with suspected OSA to identify potential diagnostic biomarkers and to provide insights into the pathophysiological mechanisms underlying the effect of OSA on AD. Methods The study included 91 consecutive AD patients who underwent overnight polysomnography (PSG) to diagnose severe OSA (apnoea‑hypopnea index ≥ 30/h). The next morning, CSF samples were collected and analysed by liquid chromatography coupled to mass spectrometry in an LC‑ESI‑QTOF‑MS/MS platform. Results The CSF levels of 11 lipid species were significantly different between AD patients with (N = 38) and without (N = 58) severe OSA. Five lipids (including oxidized triglyceride OxTG(57:2) and four unknown lipids) were significantly correlated with specific PSG measures of OSA severity related to sleep fragmentation and hypoxemia. Our analyses revealed a 4‑lipid signature (including oxidized ceramide OxCer(40:6) and three unknown lipids) that provided an accuracy of 0.80 (95% CI: 0.71–0.89) in the detection of severe OSA. These lipids increased the discriminative power of the STOP‑Bang questionnaire in terms of the area under the curve (AUC) from 0.61 (0.50–0.74) to 0.85 (0.71–0.93). Conclusions Our results reveal a CSF lipidomic fingerprint that allows the identification of AD patients with severe OSA. Our findings suggest that an increase in central nervous system lipoxidation may be the principal mechanism underlying the association between OSA and AD., Government of Catalonia, Department of Health (PERIS 2019 SLT008/18/00050), the Agency for the Management of University and Research Grants (2021 SGR 00761), and “Fundació La Marató TV3” (464/C/2014) to GPR. The Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades), co‑financed by FEDER funds from the European Union “A way to build Europe” (grant RTI2018‑099200‑B‑I00), the IRBLleida‑Diputació de Lleida (PIRS2021), and the Government of Catalonia: Agency for Management of University and Research Grants (2017SGR696) to RP. IRBLleida is a CERCA Program of the Government of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease

  • Dakterzada, Farida
  • Jové Font, Mariona
  • Huerto Vilas, Raquel
  • Carnes Vendrell, Anna
  • Sol, Joaquim
  • Pamplona Gras, Reinald
  • Piñol Ripoll, Gerard
Aberrant lipid metabolism has been strongly linked to Alzheimer’s disease (AD) pathogenesis. However, the role of lipids in the pathophysiological processes of AD and their clinical progression is unclear. We hypothesized that plasma lipids are associated with the pathological hallmarks of AD, progression from mild cognitive impairment (MCI) to AD, and the rate of cognitive decline in MCI patients. To evaluate our hypotheses, we analysed the plasma lipidome profile by liquid chromatography coupled to mass spectrometry in an LC-ESI-QTOF-MS/MS platform for 213 subjects recruited consecutively: 104 AD, 89 MCI, and 20 control subjects. Forty-seven (52.8%) MCI patients progressed to AD during follow-up (58 ± 12.5 months). We found that higher plasma levels of sphingomyelin SM(36:0) and diglyceride DG(44:3) were associated with an increased risk of amyloid beta 42 (Aβ42) positivity in CSF, while levels of SM(40:1) were associated with a reduced risk. Higher plasma levels of ether-linked triglyceride TG(O-60:10) were negatively associated with pathological levels of phosphorylated tau in CSF. Plasma levels of fatty acid ester of hydroxy fatty acid FAHFA(34:0) and ether-linked phosphatidylcholine PC(O-36:1) were positively associated with pathological levels of total tau in CSF. Regarding the plasma lipids most associated with progression from MCI to AD, our analysis detected phosphatidyl-ethanolamine plasmalogen PE(P-36:4), TG(59:12), TG(46:0), and TG(O-62:7). Furthermore, TG(O-62:7) was the lipid that was most strongly associated with the rate of progression. In conclusion, our results indicate that neutral and ether-linked lipids are involved in the pathophysiological processes of AD and the progression from MCI to AD dementia, suggesting the involvement of lipid-mediated antioxidant mechanisms in AD., We would like to express our sincere gratitude to all of the patients and all of the members of the dementia unit at the Hospital Universitari Santa Maria. Mariona Jové is a ‘Serra-Hunter’ Fellow. Farida Dakterzada was supported by the Agency for Management of University and Research Grants and the European Social Fund (FI_B100153). The Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (PI22/01687) and Agency for Management of University and Research Grants (2021SGR00761) to Gerard Piñol-Ripoll. The Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades) (grant RTI2018-099200-B-I00 and PID2022-143140- OB-I00), the IRBLleida-Diputació de Lleida (PP10605- PIRS2021), and the Government of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) to Reinald Pamplona. This study was co-financed by FEDER funds from the European Union 'A way to build Europe'. IRBLleida is a CERCA Program of the Government of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer's disease

  • Dakterzada, Farida
  • Jové Font, Mariona
  • Huerto Vilas, Raquel
  • Carnes Vendrell, Anna
  • Sol, Joaquim
  • Pamplona Gras, Reinald
  • Piñol Ripoll, Gerard
Genetic, metabolic, and clinical evidence links lipid dysregulation to an increased risk of Alzheimer's disease (AD). However, the role of lipids in the pathophysiological processes of AD and its clinical progression is unclear. We investigated the association between cerebrospinal fluid (CSF) lipidome and the pathological hallmarks of AD, progression from mild cognitive impairment (MCI) to AD, and the rate of cognitive decline in MCI patients. The CSF lipidome was analyzed by liquid chromatography coupled to mass spectrometry in an LC-ESI-QTOF-MS/MS platform for 209 participants: 91 AD, 92 MCI, and 26 control participants. The MCI patients were followed up for a median of 58 (± 12.5) months to evaluate their clinical progression to AD. Forty-eight (52.2%) MCI patients progressed to AD during follow-up. We found that higher CSF levels of hexacosanoic acid and ceramide Cer(d38:4) were associated with an increased risk of amyloid beta 42 (Aβ42) positivity in CSF, while levels of phosphatidylethanolamine PE(40:0) were associated with a reduced risk. Higher CSF levels of sphingomyelin SM(30:1) were positively associated with pathological levels of phosphorylated tau in CSF. Cholesteryl ester CE(11D3:1) and an unknown lipid were recognized as the most associated lipid species with MCI to AD progression. Furthermore, TG(O-52:2) was identified as the lipid most strongly associated with the rate of progression. Our results indicate the involvement of membrane and intracellular neutral lipids in the pathophysiological processes of AD and the progression from MCI to AD dementia. Therefore, CSF neutral lipids can be used as potential prognostic markers for AD., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. Government of Catalonia, Department of Health (PERIS 2019 SLT008/18/00050), and the Agency for the Management of University and Research Grants (2021SGR00761) to GPR. The Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades), cof inanced by FEDER funds from the European Union “A way to build Europe” (grant RTI2018-099200-B-I00), the IRBLleidaDiputació de Lleida (PP10605-PIRS2021), and the Government of Catalonia: Agency for the Management of University and Research Grants (2021SGR00990) to RP. IRBLleida is a CERCA Programme of the Government of Catalonia
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Up-Regulation of Specific Bioactive Lipids in Celiac Disease

  • Martín Masot, Rafael
  • Galo-Licona, José Daniel
  • Mota Martorell, Natàlia
  • Sol, Joaquim
  • Jové Font, Mariona
  • Maldonado, José
  • Pamplona Gras, Reinald
  • Nestares, Teresa
Celiac disease (CD) is an autoimmune enteropathy linked to alterations of metabolism. Currently, limited untargeted metabolomic studies evaluating differences in the plasma metabolome of CD subjects have been documented. We engage in a metabolomic study that analyzes plasma metabolome in 17 children with CD treated with a gluten-free diet and 17 healthy control siblings in order to recognize potential changes in metabolic networks. Our data demonstrates the persistence of metabolic defects in CD subjects in spite of the dietary treatment, affecting a minor but significant fraction (around 4%, 209 out of 4893 molecular features) of the analyzed plasma metabolome. The affected molecular species are mainly, but not exclusively, lipid species with a particular affectation of steroids and derivatives (indicating an adrenal gland affectation), glycerophospholipids (to highlight phosphatidic acid), glycerolipids (with a special affectation of diacylglycerols), and fatty acyls (eicosanoids). Our findings are suggestive of an activation of the diacylglycerol-phosphatidic acid signaling pathway in CD that may potentially have detrimental effects via activation of several targets including protein kinases such as mTOR, which could be the basis of the morbidity and mortality connected with untreated CD. However, more studies are necessary to validate this idea regarding CD., This research was funded by the Regional Government of Andalusia, Excellence Research (Project No P12-AGR-2581); by the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-BI00); by the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696); and by the Department of Health (SLT002/16/00250) to R.P. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia. The study was also partially funded by the grant “Investigation grant program by the Association of Celiacs and Sensitive to Gluten of the Community of Madrid”.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Low abundance of NDUFV2 and NDUFS4 subunits of the hydrophilic complex I domain and VDAC1 predicts mammalian longevity

  • Mota Martorell, Natàlia
  • Jové Font, Mariona
  • Pradas Barriga, Irene
  • Sanchez, Isabel
  • Gómez, José
  • Naudí i Farré, Alba
  • Barja, Gustavo
  • Pamplona Gras, Reinald
Mitochondrial reactive oxygen species (ROS) production, specifically at complex I (Cx I), has been widely suggested to be one of the determinants of species longevity. The present study follows a comparative approach to analyse complex I in heart tissue from 8 mammalian species with a longevity ranging from 3.5 to 46 years. Gene expression and protein content of selected Cx I subunits were analysed using droplet digital PCR (ddPCR) and western blot, respectively. Our results demonstrate: 1) the existence of species-specific differences in gene expression and protein content of Cx I in relation to longevity; 2) the achievement of a longevity phenotype is associated with low protein abundance of subunits NDUFV2 and NDUFS4 from the matrix hydrophilic domain of Cx I; and 3) long-lived mammals show also lower levels of VDAC (voltage-dependent anion channel) amount. These differences could be associated with the lower mitochondrial ROS production and slower aging rate of long-lived animals and, unexpectedly, with a low content of the mitochondrial permeability transition pore in these species., This work was supported by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (grant number PI14/00328), the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia, Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to R.P, and PR [19] BIO MET 0155 to GB.This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Lipid Adaptations against Oxidative Challenge in the Healthy Adult Human Brain

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Obis Monné, Èlia
  • Sol, Joaquim
  • Martín Garí, Meritxell
  • Ferrer, Isidre
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
It is assumed that the human brain is especially susceptible to oxidative stress, based on specific traits such as a higher rate of mitochondrial free radical production, a high content in peroxidizable fatty acids, and a low antioxidant defense. However, it is also evident that human neurons, although they are post-mitotic cells, survive throughout an entire lifetime. Therefore, to reduce or avoid the impact of oxidative stress on neuron functionality and survival, they must have evolved several adaptive mechanisms to cope with the deleterious effects of oxidative stress. Several of these antioxidant features are derived from lipid adaptations. At least six lipid adaptations against oxidative challenge in the healthy human brain can be discerned. In this work, we explore the idea that neurons and, by extension, the human brain is endowed with an important arsenal of non-pro-oxidant and antioxidant measures to preserve neuronal function, refuting part of the initial premise., Research by the authors was supported by the Spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00), the Diputació de Lleida (PP10605-PIRS2021), the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696), and Department of Health (SLT002/16/00250) to RP. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Obis Monné, Èlia
  • Sol, Joaquim
  • Martín Garí, Meritxell
  • Ferrer, Isidre
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
One of the richest tissues in lipid content and diversity of the human body is the brain. The human brain is constitutively highly vulnerable to oxidative stress. This oxidative stress is a determinant in brain aging, as well as in the onset and progression of sporadic (late-onset) Alzheimer’s disease (sAD). Glycerophospholipids are the main lipid category widely distributed in neural cell membranes, with a very significant presence for the ether lipid subclass. Ether lipids have played a key role in the evolution of the human brain compositional specificity and functionality. Ether lipids determine the neural membrane structural and functional properties, membrane trafficking, cell signaling and antioxidant defense mechanisms. Here, we explore the idea that ether lipids actively participate in the pathogenesis of sAD. Firstly, we evaluate the quantitative relevance of ether lipids in the human brain composition, as well as their role in the human brain evolution. Then, we analyze the implications of ether lipids in neural cell physiology, highlighting their inherent antioxidant properties. Finally, we discuss changes in ether lipid content associated with sAD and their physiopathological implications, and propose a mechanism that, as a vicious cycle, explains the potential significance of ether lipids in sAD., Research by the authors was supported by the Spanish Ministry of Science, Innovation, and Universities (grants RTI2018-099200-B-I00 and PID2022-143140OB-I00), the Diputació de Lleida (PP10605—PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to RP. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Cell Stress Induces Mislocalization of Transcription Factors with Mitochondrial Enrichment

  • Rossi, Chiara
  • Fernàndez, Anna
  • Torres Cabestany, Pascual
  • Ramírez-Núñez, Omar
  • Granado-Serrano, Ana Belén
  • Fontdevila Olivé, Laia
  • Povedano, Mònica
  • Pamplona Gras, Reinald
  • Ferrer, Isidre
  • Portero Otín, Manuel
Previous evidence links the formation of extranuclear inclusions of transcription factors, such as ERK, Jun, TDP-43, and REST, with oxidative, endoplasmic-reticulum, proteasomal, and osmotic stress. To further characterize its extranuclear location, we performed a high-content screening based on confocal microscopy and automatized image analyses of an epithelial cell culture treated with hydrogen peroxide, thapsigargin, epoxomicin, or sorbitol at different concentrations and times to recreate the stresses mentioned above. We also performed a subcellular fractionation of the brain from transgenic mice overexpressing the Q331K-mutated TARDBP, and we analyzed the REST-regulated mRNAs. The results show that these nuclear proteins exhibit a mitochondrial location, together with significant nuclear/extranuclear ratio changes, in a protein and stress-specific manner. The presence of these proteins in enriched mitochondrial fractions in vivo confirmed the results of the image analyses. TDP-43 aggregation was associated with alterations in the mRNA levels of the REST target genes involved in calcium homeostasis, apoptosis, and metabolism. In conclusion, cell stress increased the mitochondrial translocation of nuclear proteins, increasing the chance of proteostasis alterations. Furthermore, TDP-43 aggregation impacts REST target genes, disclosing an exciting interaction between these two transcription factors in neurodegenerative processes., This research was funded by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI 17–00134, PI20-0155) to M.P-O, from the Spanish Ministry ofScience, Innovation, and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department ofHealth (SLT002/16/00250) to RP. PT was a predoctoral fellow from the Ministerio de Educacion(FPU16/01446). CR and LF held predoctoral fellowships “Ajuts 2020 & 2021 de Promocióde laRecerca en Salut -8ª edició” from IRBLleida/Diputacióde Lleida. Support was also received inthe form of a Fundación Española para el Fomento de la Investigación de la Esclerosis Lateral Amiotrófica (FUNDELA] Grant, RedELA-Plataforma Investigación, and the Fundació Miquel Valls (Jack Van den Hoek donation]. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is funded by a Centres de Recerca de Catalunya (CERCA)Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Gene expression and regulatory factors of the mechanistic target of rapamycin (mTOR) complex 1 predict mammalian longevity, mTORC1 and longevit

  • Mota Martorell, Natàlia
  • Jové Font, Mariona
  • Pradas Barriga, Irene
  • Berdún Hernández, Rebeca
  • Sanchez, Isabel
  • Naudí i Farré, Alba
  • Garí Marsol, Eloi
  • Barja, Gustavo
  • Pamplona Gras, Reinald
Maximum longevity (ML) varies significantly across animal species, but the underlying molecular mechanisms remain poorly understood. Recent studies and omics approaches suggest that phenotypic traits of ML could to converge in the mammalian target of rapamycin (mTOR) signalling pathway. The present study is a comparative approach using heart tissue from 8 mammalian species with a ML ranging from 3.5 to 46 years. Gene expression, protein content, and concentration of regulatory metabolites of the mTOR complex 1 (mTORC1) were measured using droplet digital PCR, western blot and mass spectrometry, respectively. Our results demonstrate 1) the existence of differences species-specific in gene expression and protein content of mTORC1; 2) that the achievement of a longevity phenotype requires decreased and inhibited mTORC1; 3) decreased content of mTORC1 activators in long-lived animals, and 4) independence of phylogeny relationships on these changes. Altogether, our findings support mTORC1 down-regulation to achieve a longevous phenotype., This work was supported by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (grant number PI14/00328), the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia, Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to R.P. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Methionine Metabolism Is Down-Regulated in Heart of Long-Lived Mammals

  • Mota Martorell, Natàlia
  • Jové Font, Mariona
  • Berdún Hernández, Rebeca
  • Obis Monné, Èlia
  • Barja, Gustavo
  • Pamplona Gras, Reinald
Methionine constitutes a central hub of intracellular metabolic adaptations leading to an extended longevity (maximum lifespan). The present study follows a comparative approach analyzing methionine and related metabolite and amino acid profiles using an LC-MS/MS platform in the hearts of seven mammalian species with a longevity ranging from 3.8 to 57 years. Our findings demonstrate the existence of species-specific heart phenotypes associated with high longevity characterized by: (i) low concentration of methionine and its related sulphur-containing metabolites; (ii) low amino acid pool; and (iii) low choline concentration. Our results support the existence of heart metabotypes characterized by a down-regulation in long-lived species, supporting the idea that in longevity, less is more., This work was supported by the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), the Diputació de Lleida-IRBLleida (PP10605-PIRS2021), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696)) to R.P. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Effects of aging and methionine restriction on rat kidney metabolome

  • Pradas Barriga, Irene
  • Jové Font, Mariona
  • Cabré Cucó, Rosanna
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Mota Martorell, Natàlia
  • Pamplona Gras, Reinald
Methionine restriction (MetR) in animal models extends maximum longevity and seems to promote renoprotection by attenuating kidney injury. MetR has also been proven to affect several metabolic pathways including lipid metabolism. However, there is a lack of studies about the effect of MetR at old age on the kidney metabolome. In view of this, a mass spectrometry-based high-throughput metabolomic and lipidomic profiling was undertaken of renal cortex samples of three groups of male rats—An 8-month-old Adult group, a 26-month-old Aged group, and a MetR group that also comprised of 26-month-old rats but were subjected to an 80% MetR diet for 7 weeks. Additionally, markers of mitochondrial stress and protein oxidative damage were analyzed by mass spectrometry. Our results showed minor changes during aging in the renal cortex metabolome, with less than 59 differential metabolites between the Adult and Aged groups, which represents about 4% of changes in the kidney metabolome. Among the compounds identified are glycerolipids and lipid species derived from arachidonic acid metabolism. MetR at old age preferentially induces lipid changes affecting glycerophospholipids, docosanoids, and eicosanoids. No significant differences were observed between the experimental groups in the markers of mitochondrial stress and tissue protein damage. More than rejuvenation, MetR seems to induce a metabolic reprogramming, We acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia, Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to R.P. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). I.P. was supported by a University of Lleida Predoctoral Fellowship. R.C. and N.M.M. were supported by a Generalitat of Catalonia Predoctoral Fellowship. M.J. is a Serra Húnter Fellow.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women

  • Pradas Barriga, Irene
  • Rovira-Llopis, Susana
  • Naudí i Farré, Alba
  • Bañuls, Celia
  • Rocha, Milagros
  • Hernández-Mijares, Antonio
  • Pamplona Gras, Reinald
  • Victor, Victor M.
  • Jové Font, Mariona
Metformin is one of the treatments used for pcoS pathology decreasing body weight, plasma androgen, FSH and glucose levels. Unfortunately, there is little known about metformin’s effects on lipid metabolism, a crucial process in pcoS pathology. We have employed a lipidomic approach to explore alterations in the plasma lipid profile of patients with PCOS following metformin treatment. The aim is to offer new insights about the effect of metformin in PCOS patients. Plasma samples were obtained from 27 subjects prior to and following 12 weeks of metformin treatment. A detailed biochemical characterization and lipidomic profile was performed. Metformin reduces BMI, HOMA-IR, fSH and androstenedione and increases DHeA-S but no changes were found in glucose levels after treatment. Multivariate statistics revealed a specific lipidomic signature due to the effect of 12 weeks of metformin treatment in pcoS patients. this signature includes changes in sphingolipid metabolism suggesting a crosstalk between these lipid species and the androgenic metabolism and a decrease in oxidized lipids reinforcing that metformin treatment improves oxidative stress status. our study confirms the specific effect of metformin in lipid metabolism on women with PCOS after 12 weeks of treatment., We thank Maria Rosa Gomez and David Argiles for technical support. This research was funded by grants from Carlos III Health Institute (ISCIII) (PI16/1083, PI16/0301) to V.M.V and M.R, respectively and CIBERehd (CB06/04/0071)−initiatives of the ISCIII to M.R and V.M.V, the European Regional Development Fund (ERDF “A way to build Europe”). Unrestricted grant from Menarini S.A to M.R. V.M.V. and M.R. are recipients of contracts from the Ministry of Health of the Valencian Regional Government and Carlos III Health Institute (CES10/030 and CP10/0360, respectively). R. P. is recipient of contracts from the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (grant number PI14/00328); Spanish Ministry of Science, Innovation and Universities (grant number RTI2018-099200-B-I00), and the Generalitat of Catalonia, Department of Health (grant number SLT002/16/00250) and Department of Business and Knowledge (grant number 2017SGR696). This study has been co-financed by FEDER funds from the European Union (‘A way to build Europe’). I.P. received a predoctoral fellowship from the Lleida University. S.R-LL. is recipient of a Juan de la Cierva contract from Spanish Ministry of Economy and Competitiveness (FJCI-2015-25040). C.B. is recipient of a Sara Borrell contract from Institute of Health Carlos III (CD14/00043). M.J is a Serra Húnter Fellow.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Manipulating mtDNA in vivo reprograms metabolism via novel response mechanisms

  • Bahhir, Diana
  • Yalgin, Cagri
  • Ots, Liina
  • Järvinen, Sampsa
  • George, Jack
  • Naudí i Farré, Alba
  • Krama, Tatjana
  • Krams, Indrikis
  • Tamm, Mairi
  • Andjelković, Ana
  • Dufour, Eric
  • González de Cosar, Jose M.
  • Gerards, Mike
  • Parhiala, Mikael
  • Pamplona Gras, Reinald
  • Jacobs, Howard T.
  • Jõers, Priit
Mitochondria have been increasingly recognized as a central regulatory nexus for multiple metabolic pathways, in addition to ATP production via oxidative phosphorylation (OXPHOS). Here we show that inducing mitochondrial DNA (mtDNA) stress in Drosophila using a mitochondrially-targeted Type I restriction endonuclease (mtEcoBI) results in unexpected metabolic reprogramming in adult flies, distinct from effects on OXPHOS. Carbohydrate utilization was repressed, with catabolism shifted towards lipid oxidation, accompanied by elevated serine synthesis. Cleavage and translocation, the two modes of mtEcoBI action, repressed carbohydrate rmetabolism via two different mechanisms. DNA cleavage activity induced a type II diabetes-like phenotype involving deactivation of Akt kinase and inhibition of pyruvate dehydrogenase, whilst translocation decreased post-translational protein acetylation by cytonuclear depletion of acetyl-CoA (AcCoA). The associated decrease in the concentrations of ketogenic amino acids also produced downstream effects on physiology and behavior, attributable to decreased neurotransmitter levels. We thus provide evidence for novel signaling pathways connecting mtDNA to metabolism, distinct from its role in supporting OXPHOS., This work was supported by following grants: Academy of Finland postdoctoral grant nr. 132997 and exploratory research grant nr. PUT573 from Estonian Research Council to Priit Jõers; Academy Professorship (255365) and Centre of Excellence grants (272376 and 307431) by Academy of Finland to Howard T Jacobs; Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), the Generalitat of Catalonia, Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250), and by FEDER funds from European Union (“A way to build Europe”) to Reinald Pamplona; Vilho Rossin Fund (Finnish Cultural Foundation) grant to Ana Andjelković; Estonian Research Council grant nr. PUT1223 and Latvian Council of Science grant nr. lzp-2018/1-0393 to Indrikis Krams, IUT36-2 to Tatjana Krama; and AFM grant nr. 17424 to Eric Dufour. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Elovl2-Ablation Leads to Mitochondrial Membrane Fatty Acid Remodeling and Reduced Efficiency in Mouse Liver Mitochondria

  • Gómez Rodríguez, Alexia
  • Talamonti, Emanuela
  • Naudí i Farré, Alba
  • Kalinovich, Anastasia V.
  • Pauter, Anna M.
  • Barja, Gustavo
  • Bengtsson, Tore
  • Jacobsson, Anders
  • Pamplona Gras, Reinald
  • Shabalina, Irina G.
The fatty acid elongase elongation of very long-chain fatty acids protein 2 (ELOVL2)controls the elongation of polyunsaturated fatty acids (PUFA) producing precursors for omega-3,docosahexaenoic acid (DHA), and omega-6, docosapentaenoic acid (DPAn-6)in vivo. Expectedly,Elovl2-ablation drastically reduced the DHA and DPAn-6 in liver mitochondrial membranes. Unex-pectedly, however, total PUFAs levels decreased further than could be explained by Elovl2 ablation.The lipid peroxidation process was not involved in PUFAs reduction since malondialdehyde-lysine(MDAL) and other oxidative stress biomarkers were not enhanced. The content of mitochondrialrespiratory chain proteins remained unchanged. Still, membrane remodeling was associated withthe high voltage-dependent anion channel (VDAC) and adenine nucleotide translocase 2 (ANT2),a possible reflection of the increased demand on phospholipid transport to the mitochondria. Mi-tochondrial function was impaired despite preserved content of the respiratory chain proteins andthe absence of oxidative damage. Oligomycin-insensitive oxygen consumption increased, and coeffi-cients of respiratory control were reduced by 50%. The mitochondria became very sensitive to fattyacid-induced uncoupling and permeabilization, where ANT2 is involved. Mitochondrial volume andnumber of peroxisomes increased as revealed by transmission electron microscopy. In conclusion,the results imply that endogenous DHA production is vital for the normal function of mouse livermitochondria and could be relevant not only for mice but also for human metabolism., This study was supported by grants from the Swedish Science Council (VR-NT 2017-04715and VR-MT 2019-01508). This research was also funded in part by the Spanish Ministry of Science,Innovation, and Universities (grant RTI2018-099200-B-I00), and the Generalitat of Catalonia: Agencyfor Management of University and Research Grants (2017SGR696) to R.P. This study was co-financedby FEDER funds from the European Union (“A way to build Europe”). IRB Lleida is a CERCAProgramme/Generalitat of Catalonia. Open access funding was provided by Stockholm University,Sweden.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Alterations in one-carbon metabolism in celiac disease

  • Martin-Masot, Rafael
  • Mota Martorell, Natàlia
  • Jové Font, Mariona
  • Maldonado, José
  • Pamplona Gras, Reinald
  • Nestares, Teresa
Celiac disease (CD) is an autoimmune enteropathy associated with alterations of metabolism. Metabolomics studies, although limited, showed changes in choline, choline-derived lipids, and methionine concentrations, which could be ascribed to alterations in one-carbon metabolism. To date, no targeted metabolomics analysis investigating differences in the plasma choline/methionine metabolome of CD subjects are reported. This work is a targeted metabolomic study that analyzes 37 metabolites of the one-carbon metabolism in 17 children with CD, treated with a gluten-free diet and 17 healthy control siblings, in order to establish the potential defects in this metabolic network. Our results demonstrate the persistence of defects in the transsulfuration pathway of CD subjects, despite dietary treatment, while choline metabolism, methionine cycle, and folate cycle seem to be reversed and preserved to healthy levels. These findings describe for the first time, a metabolic defect in one-carbon metabolism which could have profound implications in the physiopathology and treatment of CD., This research was funded by the Regional Government of Andalusia, Excellence Research Project No P12-AGR-2581, the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-BI00), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696), and Department of Health (SLT002/16/00250) to RP. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia. It was also partially funded with the grant “Investigation grant program by the SPAO” 2020 edition
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

The lipidome fingerprint of longevity

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Pradas Barriga, Irene
  • Galo-Licona, José Daniel
  • Martín Garí, Meritxell
  • Obis Monné, Èlia
  • Sol, Joaquim
  • Pamplona Gras, Reinald
Lipids were determinants in the appearance and evolution of life. Recent studies disclose the existence of a link between lipids and animal longevity. Findings from both comparative studies and genetics and nutritional interventions in invertebrates, vertebrates, and exceptionally long-lived animal species—humans included—demonstrate that both the cell membrane fatty acid profile and lipidome are a species-specific optimized evolutionary adaptation and traits associated with longevity. All these emerging observations point to lipids as a key target to study the molecular mechanisms underlying differences in longevity and suggest the existence of a lipidome profile of long life., Research by the authors was supported by the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-BI00), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to RP. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Long-lived Humans Have a Unique Plasma Sphingolipidome

  • Pradas Barriga, Irene
  • Jové Font, Mariona
  • Huynh, Kevin
  • Inglés, Marta
  • Borrás, Consuelo
  • Mota Martorell, Natàlia
  • Galo-Licona, José Daniel
  • Puig, Josep
  • Viña Ribes, José
  • Meikle, Peter J.
  • Pamplona Gras, Reinald
A species-specific lipidome profile is an inherent feature linked to longevity in the animal kingdom. However, there is a lack of lipidomic studies on human longevity. Here, we use mass spectrometry-based lipidomics to detect and quantify 151 sphingolipid molecular species and use these to define a phenotype of healthy humans with exceptional life span. Our results demonstrate that this profile specifically comprises a higher content of complex glycosphingolipids (hexosylceramides and gangliosides), and lower levels of ceramide species from the de novo pathway, sphingomyelin and sulfatide; while for ceramide-derived signaling compounds, their content remains unchanged. Our findings suggest that structural glycosphingolipids may be more relevant to achieve the centenarian condition than signaling sphingolipids., We acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00) and the Generalitat of Catalonia, Agency for management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to R.P., and Spanish Ministry of Education and Science (SAF2013-44663-R) and the ‘Red Tematica de Investigación Cooperativa en Envejecimiento y Fragilidad’ (RETICEF) (ISCIII2012-RED-43-029) to J.V. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). I.P. was supported by a University of Lleida Predoctoral Fellowship. K.H. was supported by a Dementia Australia Research Foundation Scholarship.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Phenotypic molecular features of long-lived animal species

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Fernández Bernal, Anna
  • Portero Otín, Manuel
  • Barja, Gustavo
  • Pamplona Gras, Reinald
One of the challenges facing science/biology today is uncovering the molecular bases that support and determine animal and human longevity. Nature, in offering a diversity of animal species that differ in longevity by more than 5 orders of magnitude, is the best ‘experimental laboratory’ to achieve this aim. Mammals, in particular, can differ by more than 200-fold in longevity. For this reason, most of the available evidence on this topic derives from comparative physiology studies. But why can human beings, for instance, reach 120 years whereas rats only last at best 4 years? How does nature change the longevity of species? Longevity is a species-specific feature resulting from an evolutionary process. Long-lived animal species, including humans, show adaptations at all levels of biological organization, from metabolites to genome, supported by signaling and regulatory networks. The structural and functional features that define a long-lived species may suggest that longevity is a programmed biological property., Research by the authors was supported by the Spanish Ministry of Science, Innovation, and Universities (grants RTI2018-099200-B-I00), the Diputació de Lleida (PP10605—PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to RP. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Cognitive Training with Modern Board and Card Games in Healthy Older Adults: Two Randomized Controlled Trials

  • Estrada Plana, Verónica
  • Montanera, Roger
  • Ibarz Estruga, Ana
  • March Llanes, Jaume
  • Vita Barrull, Núria
  • Guzmán, Núria
  • Ros Morente, Agnès
  • Ayesa, Rosa
  • Moya Higueras, Jorge
Objectives. The aim of this study was to assess the effectiveness of a cognitive intervention based on modern board and card games. Methods. We conducted two two-arm parallel-group, randomized controlled trials. The first one (pilot study) was non-blind. The second one (main study) was a doubleblind design. Participants (14 in a pilot study and 35 in the main study) were healthy older adults over 65 years old who were assisting to adult care institutions. In the pilot study, participants in the experimental group (n=6) played modern board and card games which activated cognitive processes; whereas the control group (n=6) was in the wait-list condition. In the main study, participants in the experimental group (n=12) also played modern board and card games; whereas the control group (n=15) performed standardized paper-and-pencil cognitive tasks. Psychologists specialized in older-people conducted all the interventions. In both studies, intervention sessions were bi-weekly for 5 weeks. The outcomes of both studies were cognitive status and executive functioning, depressive symptomatology, and quality of life measures. All assessment and intervention sessions took place in their habitual centers. Results. In the pilot study, participants in the games intervention showed a significant improvement in semantic verbal fluency. In the main study, both interventions showed significant improvements in phonemic verbal fluency. Whilst board and card games maintained motor impulsivity control, paper-and-pencil tasks improved speed in an inhibition task. Conclusions. Modern board and card games could be an effective cognitive intervention to maintain some cognitive functions., We would like to express our gratitude to the participants, the centers (Balàfia I and II, and Comtes Urgell) and all their workers. Thanks to the Comissionat per a Universitats i Recerca del DIUE, Generalitat de Catalunya (2017SGR1577), to the Center for Biomedical Research Network on Mental Health (CIBERSAM), and to Spanish Ministry of Science, Innovation and Universities (MICIU/FEDER; project RTI2018‐099800‐B‐I00).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Age-Related Changes in Lipidome of Rat Frontal Cortex and Cerebellum Are Partially Reversed by Methionine Restriction Applied in Old Age

  • Jové Font, Mariona
  • Cabré, Rosanna
  • Mota Martorell, Natàlia
  • Martín Garí, Meritxell
  • Obis Monné, Èlia
  • Ramos, Paula
  • Canales , Iván
  • Galo-Licona, José Daniel
  • Sol, Joaquim
  • Nogueras Penabad, Lara
  • Torres Cabestany, Pascual
  • Portero Otín, Manuel
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Ferrer, Isidre
  • Pamplona Gras, Reinald
Lipids are closely associated with brain structure and function. However, the potential changes in the lipidome induced by aging remain to be elucidated. In this study, we used chromatographic techniques and a mass spectrometry-based approach to evaluate age-associated changes in the lipidome of the frontal cortex and cerebellum obtained from adult male Wistar rats (8 months), aged male Wistar rats (26 months), and aged male Wistar rats submitted to a methionine restriction diet (MetR) as an anti-aging intervention for 8 weeks. The outcomes revealed that only small changes (about 10%) were observed in the lipidome profile in the cerebellum and frontal cortex during aging, and these changes differed, in some cases, between regions. Furthermore, a MetR diet partially reversed the effects of the aging process. Remarkably, the most affected lipid classes were ether-triacylglycerols, diacylglycerols, phosphatidylethanolamine N-methylated, plasmalogens, ceramides, and cholesterol esters. When the fatty acid profile was analyzed, we observed that the frontal cortex is highly preserved during aging and maintained under MetR, whereas in the cerebellum minor changes (increased monounsaturated and decreased polyunsaturated contents) were observed and not reversed by MetR. We conclude that the rat cerebellum and frontal cortex have efficient mechanisms to preserve the lipid profile of their cell membranes throughout their adult lifespan in order to maintain brain structure and function. A part of the small changes that take place during aging can be reversed with a MetR diet applied in old age., This research was funded by the Spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696) to R.P.; and from Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI20-0155) to M.P.-O. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression

  • Sol, Joaquim
  • Jové Font, Mariona
  • Povedano, Mònica
  • Sproviero, William
  • Dominguez, Raul
  • Piñol Ripoll, Gerard
  • Romero Guevara, Ricardo
  • Hye, Abdul
  • Al-Chalabi, Ammar
  • Torres Cabestany, Pascual
  • Andrés Benito, Pol
  • Area Gomez, Estela
  • Pamplona Gras, Reinald
  • Ferrer, Isidre
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Portero Otín, Manuel
Since amyotrophic lateral sclerosis cases exhibit significant heterogeneity, we aim to investigate the association of lipid composition of plasma and CSF with amyotrophic lateral sclerosis diagnosis, its progression and clinical characteristics. Lipidome analyses would help to stratify patients on a molecular basis. For this reason, we have analysed the lipid composition of paired plasma and CSF samples from amyotrophic lateral sclerosis cases and age-matched non-amyotrophic lateral sclerosis individuals (controls) by comprehensive liquid chromatography coupled to mass spectrometry. The concentrations of neurofilament light chain—an index of neuronal damage—were also quantified in CSF samples and plasma. Amyotrophic lateral sclerosis versus control comparison, in a moderate stringency mode, showed that plasma from cases contains more differential lipids (n = 122 for raw P < 0.05; n = 27 for P < 0.01) than CSF (n = 17 for raw P < 0.05; n = 4 for P < 0.01), with almost no overlapping differential species, mainly characterized by an increased content of triacylglyceride species in plasma and decreased in CSF. Of note, false discovery rate correction indicated that one of the CSF lipids (monoacylglycerol 18:0) had high statistic robustness (false discovery rate-P < 0.01). Plasma lipidomes also varied significantly with the main involvement at onset (bulbar, spinal or respiratory). Notably, faster progression cases showed particular lipidome fingerprints, featured by decreased triacylclycerides and specific phospholipids in plasma, with 11 lipids with false discovery rate-P < 0.1 (n = 56 lipids in plasma for raw P < 0.01). Lipid species associated with progression rate clustered in a relatively low number of metabolic pathways, mainly triacylglyceride metabolism and glycerophospholipid and sphingolipid biosynthesis. A specific triacylglyceride (68:12), correlated with neurofilament content (r = 0.8, P < 0.008). Thus, the present findings suggest that systemic hypermetabolism—potentially sustained by increased triacylglyceride content—and CNS alterations of specific lipid pathways could be associated as modifiers of disease progression. Furthermore, these results confirm biochemical lipid heterogeneity in amyotrophic lateral sclerosis with different presentations and progression, suggesting the use of specific lipid species as potential disease classifiers., We acknowledge funding from the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI 17-00134, PI20-0155) to M.P-O; from the Spanish Ministry of Science, Innovation, and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia [Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)] to R.P. P.T. is a predoctoral fellow from the Ministerio de Educacion (FPU16/01446). Support was also received in the form of a Fundación Española para el Fomento de la Investigación de la Esclerosis Lateral Amiotrófica (FUNDELA) Grant, RedELA-Plataforma Investigación, and the Fundació Miquel Valls (Jack Van den Hoek donation). M.J. is a professor under the Serra Hunter program (Generalitat de Catalunya). Dr W.S. was funded by the Motor Neurone Disease Association (grant application Al-Chalabi/Apr15/844-791). This study has been co-financed by FEDER funds from the European Union (‘A way to build Europe’). IRBLleida is funded by a Centres de Recerca de Catalunya (CERCA) Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Subjects with detectable Saccharomyces cerevisiae in the gut microbiota show deficits in attention and executive function

  • Arnoriaga Rodríguez, María
  • Mayneris Perxachs, Jordi
  • Coll, Claudia
  • Pérez Brocal, Vicente
  • Ricart, Wifredo
  • Moya, Andrés
  • Ramió Torrentà, Lluís
  • Pamplona Gras, Reinald
  • Jové Font, Mariona
  • Portero Otín, Manuel
  • Fernández Real, José Manuel
This work was partially supported by researchgrants FIS (PI15/01934 and PI18/01022) from theInstituto de Salud Carlos III from Spain, SAF2015-65878-R and RTI2018-099200-B-I00 from theMinisterio de Econom ıa y Competitividad, Prome-teo/2018/A/133 from Generalitat Valenciana,Spain, and also by Fondo Europeo de DesarrolloRegional (FEDER) funds, European Commission(FP7, NeuroPain #2013-602891), the Generalitat ofCatalunya (AGAUR, #SGR2017-669, #SGR2017-696, Department of Health SLT002/16/00250;ICREA Academia Award 2015), the Instituto deSalud Carlos III from Spain (RTA, #RD16/0017/0020) and the Fondo Europeo de DesarrolloRegional (No. 01.2.2-LMT-K-718-02-0014); andby Project ThinkGut (EFA345/19), 65% co-fi-nanced by the European Regional DevelopmentFund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). Mar ıa Arnoriaga-Rodr ıguez is funded byInstituto de Salud Calos III, R ıo Hortega (CP19/00190). Jordi Mayneris-Perxachs is funded by theMiguel Servet Program from the Instituto de SaludCarlos III (ISCIII CP18/00009), co-funded by theEuropean Social Fund “Investing in your future”.Mariona Jov e is a professor under the Serra Hunterprogramme (Generalitat de Catalunya).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment

  • Andrés Benito, Pol
  • Gelpí, Ellen
  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Obis Monné, Èlia
  • Portero Otín, Manuel
  • Povedano, Mònica
  • Pujol, Aurora
  • Pamplona Gras, Reinald
  • Ferrer, Isidre
Aim. Peroxisomes play a key role in lipid metabolism, and peroxisome defects have been associated with neurodegenerative diseases such as X-adrenoleukodystrophy and Alzheimer's disease. This study aims to elucidate the contribution of peroxisomes in lipid alterations of area 8 of the frontal cortex in the spectrum of TDP43-proteinopathies. Cases of frontotemporal lobar degeneration-TDP43 (FTLD-TDP), manifested as sporadic (sFTLD-TDP) or linked to mutations in various genes including expansions of the non-coding region of C9ORF72 (c9FTLD), and of sporadic amyotrophic lateral sclerosis (sALS) as the most common TDP43 proteinopathies, were analysed. Methods. We used transcriptomics and lipidomics methods to define the steady-state levels of gene expression and lipid profiles. Results. Our results show alterations in gene expression of some components of peroxisomes and related lipid pathways in frontal cortex area 8 in sALS, sFTLD-TDP and c9FTLD. Additionally, we identify a lipidomic pattern associated with the ALS-FTLD-TDP43 proteinopathy spectrum, notably characterised by down-regulation of ether lipids and acylcarnitine among other lipid species, as well as alterations in the lipidome of each phenotype of TDP43 proteinopathy, which reveals commonalities and disease-dependent differences in lipid composition. Conclusion. Globally, lipid alterations in the human frontal cortex of the ALS-FTLD-TDP43 proteinopathy spectrum, which involve cell membrane composition and signalling, vulnerability against cellular stress and possible glucose metabolism, are partly related to peroxisome impairment., Research by the authors was supported by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI 17–00134) to M.P-O; the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (FIS grants FISPI17/000809) to IF; and by the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-BI00) and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to RP. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). Support was also received in the form of a FUNDELA Grant, RedELA-Plataforma Investigación and the Fundació Miquel Valls (Jack Van den Hoek donation). IRBLleida and IDIBELL are CERCA Programmes of the Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Selective brain regional changes in lipid profile with human aging

  • Mota Martorell, Natàlia
  • Andrés Benito, Pol
  • Martín Garí, Meritxell
  • Galo-Licona, José Daniel
  • Sol, Joaquim
  • Fernández Bernal, Anna
  • Portero Otín, Manuel
  • Ferrer, Isidre
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Fatty acids are key components in the structural diversity of lipids and play a strategic role in the functional properties of lipids which determine the integrity of neuronal and glial cell membranes, the generation of lipid signaling mediators, and the chemical reactivity of acyl chains. The present study analyzes using gas chromatography the fatty acid profiles of 13 regions of the human central nervous system in healthy individuals ranging from 40 to 80 years old. The outcomes suggest the existence of general traits in fatty acid composition such as an average chain length of 18 carbon atoms, high monounsaturated fatty acid content, and predominance in polyunsaturated fatty acids of those of series n-6 over series n-3 which are shared by all brain regions regardless of age. Our results also show a general sustained and relatively well-preserved lipid profile throughout the adult lifespan in most studied regions (olive, upper vermis, substantia nigra, thalamus, hippocampus, putamen, caudate, occipital cortex, parietal cortex, entorhinal cortex, and frontal cortex) with minor changes that are region-dependent. In contrast, of particular relevance is the involvement of the inferior temporal cortex and cingulate cortex. It is proposed that during normal human brain aging, the lipid profile is resistant to changes with age in most human brain regions to ensure cell survival and function, but some particular regions involved in specific memory domains are greatly affected., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This research was funded by the Spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00), the IRBLleida-Dipuatació de Lleida (PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696) to R.P. This study was cofnanced by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

  • Gatius Calderó, Sònia
  • Jové Font, Mariona
  • Megino-Luque, Cristina
  • Albertí Valls, Manel
  • Yeramian Hakim, Andree
  • Bonifaci, Núria
  • Pinyol, Miquel
  • Santacana Espasa, Maria
  • Pradas Barriga, Irene
  • Llobet Navàs, David
  • Pamplona Gras, Reinald
  • Matias-Guiu, Xavier
  • Eritja Sánchez, Núria
Metabolomic profiling analysis has the potential to highlight new molecules and cellular pathways that may serve as potential therapeutic targets for disease treatment. In this study, we used an LC-MS/MS platform to define, for the first time, the specific metabolomic signature of uterine serous carcinoma (SC), a relatively rare and aggressive variant of endometrial cancer (EC) responsible for 40% of all endometrial cancer-related deaths. A metabolomic analysis of 31 ECs (20 endometrial endometrioid carcinomas (EECs) and 11 SCs) was performed. Following multivariate statistical analysis, we identified 232 statistically different metabolites among the SC and EEC patient samples. Notably, most of the metabolites identified (89.2%) were lipid species and showed lower levels in SCs when compared to EECs. In addition to lipids, we also documented metabolites belonging to amino acids and purine nucleotides (such as 2-Oxo-4-methylthiobutanoic acid, synthesised by acireductone dioxygenase 1 (ADI1) enzyme), which showed higher levels in SCs. To further investigate the role of ADI1 in SC, we analysed the expression protein levels of ADI1 in 96 ECs (67 EECs and 29 SCs), proving that the levels of ADI1 were higher in SCs compared to EECs. We also found that ADI1 mRNA levels were higher in p53 abnormal ECs compared to p53 wild type tumours. Furthermore, elevated ADI1 mRNA levels showed a statistically significant negative correlation with overall survival and progression-free survival among EEC patients. Finally, we tested the ability of ADI1 to induce migration and invasion capabilities in EC cell lines. Altogether, these results suggest that ADI1 could be a potential therapeutic target in poor-prognosis SCs and other Ecs with abnormal p53 expression., This study was funded by the Instituto de Salud Carlos III (ISCIII) through projects PI20/00502, CP19/00025, CB16/12/00231, PI16/00692, PI18/00573, PI21/00672, CP17/00063 and PI18/00795; and by the Spanish Ministry of Science, Innovation and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-BI00), co-funded by the European Regional Development Fund (ERDF) as part of the “A way to make Europe” programme and the European Social Fund (ESF) as part of the “Investing in Your Future” programme. This study was also supported by the “Xarxa de Bancs de Tumors de Catalunya” and sponsored by “Pla Director d’Oncologia de Catalunya (XBTC)”, “IRBLleida Biobank” (B.0000682) and “Plataforma Biobancos” PT20/00021. We also thank the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR1368 and 2017SGR696) and the “Asociación Española Contra el Cáncer” (AECC; Grupos Estables 2018 and LABAE19004LLOB). M.J. is a Serra Húnter Fellow. N.E. (MS19/00025) and D.L-N. (MS17/00063) are recipients of a Miguel Servet research scheme (co-funded by the ESF program “Investing in Your Future”). C. M-L. holds a predoctoral fellowship from the Generalitat de Catalunya (2020FI_B2 00099) and the predoctoral fellowship “Ajuts 2021 de Promoció de la Recerca en Salut-9a edició” from IRBLleida/Diputació de Lleida. IRBLleida is a CERCA Program/Generalitat of Catalonia.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

The advanced lipoxidation end-product malondialdehyde-lysine in aging and longevity

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Pradas Barriga, Irene
  • Martín Garí, Meritxell
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Pamplona Gras, Reinald
The nonenzymatic adduction of malondialdehyde (MDA) to the protein amino groups leads to the formation of malondialdehyde-lysine (MDALys). The degree of unsaturation of biological membranes and the intracellular oxidative conditions are the main factors that modulate MDALys formation. The low concentration of this modification in the different cellular components, found in a wide diversity of tissues and animal species, is indicative of the presence of a complex network of cellular protection mechanisms that avoid its cytotoxic effects. In this review, we will focus on the chemistry of this lipoxidation-derived protein modification, the specificity of MDALys formation in proteins, the methodology used for its detection and quantification, the MDA-lipoxidized proteome, the metabolism of MDA-modified proteins, and the detrimental effects of this protein modification. We also propose that MDALys is an indicator of the rate of aging based on findings which demonstrate that (i) MDALys accumulates in tissues with age, (ii) the lower the concentration of MDALys the greater the longevity of the animal species, and (iii) its concentration is attenuated by anti-aging nutritional and pharmacological interventions, Research by the authors was supported by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (FIS grants PI13/00584 and PI14/00328), the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-BI00), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696), and Department of Health (SLT002/16/00250) to RP. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metabolic pathways

  • Arnoriaga-Rodríguez, María
  • Mayneris-Perxachs, Jordi
  • Contreras-Rodríguez, Oren
  • Burokas, Aurelijus
  • Ortega-Sanchez, Juan-Antonio
  • Blasco, Gerard
  • Coll, Clàudia
  • Biarnés, Carles
  • Castells-Nobau, Anna
  • Puig, Josep
  • Garre-Olmo, Josep
  • Ramos, Rafel
  • Pedraza, Salvador
  • Brugada, Ramon
  • Vilanova, Joan C.
  • Serena, Joaquín
  • Barretina, Jordi
  • Gich, Jordi
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Fernández-Real, Xavier
  • Ramió-Torrentà, Lluís
  • Pamplona, Reinald
  • Sol, Joaquim
  • Jové, Mariona
  • Ricart, Wifredo
  • Portero-Otín, Manuel
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
Gut: first published., [Background]: Inhibitory control (IC) is critical to keep long-term goals in everyday life. Bidirectional relationships between IC deficits and obesity are behind unhealthy eating and physical exercise habits., [Methods]: We studied gut microbiome composition and functionality, and plasma and faecal metabolomics in association with cognitive tests evaluating inhibitory control (Stroop test) and brain structure in a discovery (n=156), both cross-sectionally and longitudinally, and in an independent replication cohort (n=970). Faecal microbiota transplantation (FMT) in mice evaluated the impact on reversal learning and medial prefrontal cortex (mPFC) transcriptomics., [Results]: An interplay among IC, brain structure (in humans) and mPFC transcriptomics (in mice), plasma/faecal metabolomics and the gut metagenome was found. Obesity-dependent alterations in one-carbon metabolism, tryptophan and histidine pathways were associated with IC in the two independent cohorts. Bacterial functions linked to one-carbon metabolism (thyX,dut, exodeoxyribonuclease V), and the anterior cingulate cortex volume were associated with IC, cross-sectionally and longitudinally. FMT from individuals with obesity led to alterations in mice reversal learning. In an independent FMT experiment, human donor’s bacterial functions related to IC deficits were associated with mPFC expression of one-carbon metabolism-related genes of recipient’s mice., [Conclusion]: These results highlight the importance of targeting obesity-related impulsive behaviour through the induction of gut microbiota shifts., This work was partially supported by research grants FIS (PI15/01934 and PI18/01022) from the Instituto de Salud Carlos III from Spain, SAF2015-65878-R and #AEI-SAF2017-84060-R-FEDER from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain; and also by Fondo Europeo de Desarrollo Regional (FEDER) funds, European Commission (FP7, NeuroPain #2013-602891), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2015), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020), the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), the Catalan Goverment (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [STL002/16/00250]; the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and the Project ThinkGut (EFA345/19) 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A SpainFrance-Andorra programme (POCTEFA 2014-2020). MA-R is funded by a predoctoral Río Hortega contract from the Instituto de Salud Carlos III (ISCIII, CM19/00190), co-funded by the European Social Fund “Investing in your future”. OC-R is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP20/00165), co-funded by the Europeran Social Fund "Investing in your future". JM-P is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP18/00009), co-funded by the European Social Fund “Investing in your future”. JS is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. MJ is a professor under the “Serra Hunter” programme (Generalitat de Catalunya)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Obesity impairs short-term and working memory through gut microbial metabolism of aromatic amino acids

  • Arnoriaga-Rodríguez, María
  • Mayneris-Perxachs, Jordi
  • Burokas, Aurelijus
  • Contreras-Rodríguez, Oren
  • Blasco, Gerard
  • Coll, Clàudia
  • Biarnés, Carles
  • Miranda-Olivos, Romina
  • Latorre, Jèssica
  • Moreno-Navarrete, José Maria
  • Castells-Nobau, Anna
  • Sabater-Masdeu, Mònica
  • Palomo-Buitrago, María Encarnación
  • Puig, Josep
  • Pedraza, Salvador
  • Gich, Jordi
  • Pérez-Brocal, Vicente
  • Ricart, Wifredo
  • Moya, Andrés
  • Fernández-Real, Xavier
  • Ramió-Torrentà, Lluís
  • Pamplona, Reinald
  • Sol, Joaquim
  • Jové, Mariona
  • Portero-Otín, Manuel
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
The gut microbiome has been linked to fear extinction learning in animal models. Here, we aimed to explore the gut microbiome and memory domains according to obesity status. A specific microbiome profile associated with short-term memory, working memory, and the volume of the hippocampus and frontal regions of the brain differentially in human subjects with and without obesity. Plasma and fecal levels of aromatic amino acids, their catabolites, and vegetable-derived compounds were longitudinally associated with short-term and working memory. Functionally, microbiota transplantation from human subjects with obesity led to decreased memory scores in mice, aligning this trait from humans with that of recipient mice. RNA sequencing of the medial prefrontal cortex of mice revealed that short-term memory associated with aromatic amino acid pathways, inflammatory genes, and clusters of bacterial species. These results highlight the potential therapeutic value of targeting the gut microbiota for memory impairment, specifically in subjects with obesity., This work was partially supported by FIS research grants (PI15/01934 and PI18/01022) from the Instituto de Salud Carlos III, Spain; SAF2015-65878-R and #AEI-SAF2017-84060-R FEDER from Ministry of Economy and Competitiveness; Prometeo/2018/A/133 from Generalitat Valenciana, Spain; and also by Fondo Europeo de Desarrollo Regional (FEDER) funds; European Commission (FP7, NeuroPain #2013-602891); the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2015); the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020); the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00); the Catalan Government (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [SLT002/16/00250]); the European Regional Development Fund (project no. 1.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and Fondo Europeo de Desarrollo Regional (FEDER) through the Programa Interreg V-A España-Francia-Andorra (POCTEFA 2014-2020). M.A.-R. is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190, co-funded by European Social Fund “Investing in your future”). O.C.-R. is funded by a postdoctoral “PERIS” contract (SLT006/17/00236) from the Catalan Government, 2017, Spain. J.M.-P. is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII, CP18/00009, co-funded by the European Social Fund “Investing in your future”). J.S. is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. M.J. is a professor under the Serra Hunter program (Generalitat de Catalunya)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Subjects with detectable Saccharomyces cerevisiae in the gut microbiota show deficits in attention and executive function

  • Arnoriaga-Rodríguez, María
  • Mayneris-Perxachs, Jordi
  • Coll, Clàudia
  • Pérez-Brocal, Vicente
  • Ricart, Wifredo
  • Moya, Andrés
  • Ramió-Torrentà, Lluís
  • Pamplona, Reinald
  • Jové, Mariona
  • Portero-Otín, Manuel
  • Fernández-Real, José Manuel
This work was partially supported by research grants FIS (PI15/01934 and PI18/01022) from the Instituto de Salud Carlos III from Spain, SAF2015-65878-R and RTI2018-099200-B-I00 from the Ministerio de Economía y Competitividad, Prometeo/2018/A/133 from Generalitat Valenciana, Spain, and also by Fondo Europeo de Desarrollo Regional (FEDER) funds, European Commission (FP7, NeuroPain #2013-602891), the Generalitat of Catalunya (AGAUR, #SGR2017-669, #SGR2017-696, Department of Health SLT002/16/00250; ICREA Academia Award 2015), the Instituto de Salud Carlos III from Spain (RTA, #RD16/0017/0020) and the Fondo Europeo de Desarrollo Regional (No. 01.2.2-LMT-K-718-02-0014); and by Project ThinkGut (EFA345/19), 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). María Arnoriaga-Rodríguez is funded by Instituto de Salud Calos III, Río Hortega (CP19/00190). Jordi Mayneris-Perxachs is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP18/00009), co-funded by the European Social Fund “Investing in your future”. Mariona Jové is a professor under the Serra Hunter programme (Generalitat de Catalunya)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Caudovirales bacteriophages are associated with improved executive function and memory in flies, mice, and humans

  • Mayneris-Perxachs, Jordi
  • Castells-Nobau, Anna
  • Arnoriaga-Rodríguez, María
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafel
  • Martínez-Hernández, Francisco
  • Burokas, Aurelijus
  • Coll, Clàudia
  • Moreno-Navarrete, José Maria
  • Zapata-Tona, Cristina
  • Pedraza, Salvador
  • Pérez-Brocal, Vicente
  • Ramió-Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Martínez-García, Manuel
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
Growing evidence implicates the gut microbiome in cognition. Viruses, the most abundant life entities on the planet, are a commonly overlooked component of the gut virome, dominated by the Caudovirales and Microviridae bacteriophages. Here, we show in a discovery (n = 114) and a validation cohort (n = 942) that subjects with increased Caudovirales and Siphoviridae levels in the gut microbiome had better performance in executive processes and verbal memory. Conversely, increased Microviridae levels were linked to a greater impairment in executive abilities. Microbiota transplantation from human donors with increased specific Caudovirales (>90% from the Siphoviridae family) levels led to increased scores in the novel object recognition test in mice and up-regulated memory-promoting immediate early genes in the prefrontal cortex. Supplementation of the Drosophila diet with the 936 group of lactococcal Siphoviridae bacteriophages resulted in increased memory scores and upregulation of memory-involved brain genes. Thus, bacteriophages warrant consideration as novel actors in the microbiome-brain axis., This work was partially funded by the Instituto de Salud Carlos III (Madrid, Spain) through the project PI15/01934, PI18/01022, PI21/01361) to J.M.F.-R. and the project PI20/01090 (co-funded by the European Regional Development Fund. “A way to make Europe”) to J.M.-P., the grants SAF2015-65878-R from the Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by the Fondo Europeo de Desarrollo Regional (FEDER) funds, European Commission (FP7, NeuroPain #2013-602891), the Catalan Government (AGAUR, #SGR2017-669, #2017 SGR- 734, ICREA Academia Award 2015 to R.M. and ICREA Academia Award 2022 to J.M.F.R.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020), the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT), and the Project ThinkGut (EFA345/19) 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). CIBERobn is also co-funded by the European Regional Development Fund. We also acknowledge the funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research grants (2017SGR696) and Department of Health (SLT002/16/00250)) to R.M M.A.-R. is funded by the Instituto de Salud Carlos III, Río Hortega (CM19/00190). J.M.-P. is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP18/00009), co-funded by the European Social Fund “Investing in your future.” A.C.-N. is funded by the Instituto de Salud Carlos III, Sara Borrell. MMG was funded by the Spanish Ministry of Science, Innovation and Universities RTI2018-094248-B-I00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microbiota alterations in proline metabolism impact depression

  • Mayneris-Perxachs, Jordi
  • Castells-Nobau, Anna
  • Arnoriaga-Rodríguez, María
  • Martin, Miquel
  • Vega-Correa, Lisset de la
  • Zapata-Tona, Cristina
  • Burokas, Aurelijus
  • Blasco, Gerard
  • Coll, Clàudia
  • Escrichs, Anira
  • Biarnés, Carles
  • Moreno-Navarrete, José Maria
  • Puig, Josep
  • Garre-Olmo, Josep
  • Ramos, Rafel
  • Pedraza, Salvador
  • Brugada, Ramon
  • Vilanova, Joan C.
  • Serena, Joaquín
  • Gich, Jordi
  • Ramió-Torrentà, Lluís
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Pamplona, Reinald
  • Sol, Joaquim
  • Jové, Mariona
  • Ricart, Wifredo
  • Portero-Otín, Manuel
  • Deco, Gustavo
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with low treatment efficacy. However, the field is dominated by underpowered studies focusing on major depression not addressing microbiome functionality, compositional nature, or confounding factors. We applied a multi-omics approach combining pre-clinical models with three human cohorts including patients with mild depression. Microbial functions and metabolites converging onto glutamate/GABA metabolism, particularly proline, were linked to depression. High proline consumption was the dietary factor with the strongest impact on depression. Whole-brain dynamics revealed rich club network disruptions associated with depression and circulating proline. Proline supplementation in mice exacerbated depression along with microbial translocation. Human microbiota transplantation induced an emotionally impaired phenotype in mice and alterations in GABA-, proline-, and extracellular matrix-related prefrontal cortex genes. RNAi-mediated knockdown of proline and GABA transporters in Drosophila and mono-association with L. plantarum, a high GABA producer, conferred protection against depression-like states. Targeting the microbiome and dietary proline may open new windows for efficient depression treatment., This work was partially supported by Instituto de Salud Carlos III (Madrid, Spain) through the research grants PI15/01934, PI18/01022, and PI21/01361 to J.M.F.-R. and PI20/01090 (co-funded by the European Regional Development Fund. “A way to make Europe”) to J.M.-P.; the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R.; the Spanish Ministry of Science, Innovation and Universities (PID2019-105969GB-I00); Generalitat Valenciana (Prometeo/2018/133), Spain; and Fondo Europeo de Desarrollo Regional (FEDER) funds to A.M. This work was also supported by the European Commission (FP7, NeuroPain #2013-602891); the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020) to R.M.; the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) to R.M.; Ministry of Science and Innovation and State Research Agency (#PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033) to R.M.; the European Regional Development Fund (project no. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and the Project ThinkGut (EFA345/19), 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra program (POCTEFA, 2014–2020). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00) and the Generalitat of Catalonia (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [SLT002/16/00250]) to R.P. M.A.-R. is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). J.M.-P. is funded by a Miguel Servet contract (CP18/00009) from the Instituto de Salud Carlos III. J.S. is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. M.J. is a professor under “Serra Hunter” program (Generalitat de Catalunya)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipidomic alterations in the cerebral cortex and white matter in sporadic Alzheimer's disease.

  • Obis Monné, Èlia
  • Sol, Joaquim
  • Andrés Benito, Pol
  • Martín Garí, Meritxell
  • Mota Martorell, Natàlia
  • Galo-Licona, José Daniel
  • Piñol Ripoll, Gerard
  • Portero Otín, Manuel
  • Ferrer, Isidro
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Non-targeted LC-MS/MS-based lipidomic analysis was conducted in post-mortem human grey matter frontal cortex area 8 (GM) and white matter of the frontal lobe centrum semi-ovale (WM) to identify lipidome fingerprints in middle-aged individuals with no neurofibrillary tangles and senile plaques, and cases at progressive stages of sporadic Alzheimer's disease (sAD). Complementary data were obtained using RT-qPCR and immunohistochemistry. The results showed that WM presents an adaptive lipid phenotype resistant to lipid peroxidation, characterized by a lower fatty acid unsaturation, peroxidizability index, and higher ether lipid content than the GM. Changes in the lipidomic profile are more marked in the WM than in GM in AD with disease progression. Four functional categories are associated with the different lipid classes affected in sAD: membrane structural composition, bioenergetics, antioxidant protection, and bioactive lipids, with deleterious consequences affecting both neurons and glial cells favoring disease progression., This research was funded by the Spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00, and PID2022-143140OB-I00), the Diputació de Lleida-IRBLleida (PP10605 – PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) to R.P., and Instituto de Salud Carlos III grant (PI20/00155) to M.P.O. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia. Part of the study was also funded by “La Caixa” Foundation under the agreement LCF/PR/HR19/ 52160007: HR18-00452 to I.F. M.J. is a ‘Serra-Hunter’ Fellow. We thank T. Yohannan for editorial help.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Obis Monné, Èlia
  • Sol, Joaquim
  • Martín Garí, Meritxell
  • Ferrer, Isidre
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
One of the richest tissues in lipid content and diversity of the human body is the brain. The human brain is constitutively highly vulnerable to oxidative stress. This oxidative stress is a determinant in brain aging, as well as in the onset and progression of sporadic (late-onset) Alzheimer’s disease (sAD). Glycerophospholipids are the main lipid category widely distributed in neural cell membranes, with a very significant presence for the ether lipid subclass. Ether lipids have played a key role in the evolution of the human brain compositional specificity and functionality. Ether lipids determine the neural membrane structural and functional properties, membrane trafficking, cell signaling and antioxidant defense mechanisms. Here, we explore the idea that ether lipids actively participate in the pathogenesis of sAD. Firstly, we evaluate the quantitative relevance of ether lipids in the human brain composition, as well as their role in the human brain evolution. Then, we analyze the implications of ether lipids in neural cell physiology, highlighting their inherent antioxidant properties. Finally, we discuss changes in ether lipid content associated with sAD and their physiopathological implications, and propose a mechanism that, as a vicious cycle, explains the potential significance of ether lipids in sAD., Research by the authors was supported by the Spanish Ministry of Science, Innovation, and Universities (grants RTI2018-099200-B-I00 and PID2022-143140OB-I00), the Diputació de Lleida (PP10605—PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to RP. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Methionine Metabolism Is Down-Regulated in Heart of Long-Lived Mammals

  • Mota Martorell, Natàlia
  • Jové Font, Mariona
  • Berdún Hernández, Rebeca
  • Obis Monné, Èlia
  • Barja, Gustavo
  • Pamplona Gras, Reinald
Methionine constitutes a central hub of intracellular metabolic adaptations leading to an extended longevity (maximum lifespan). The present study follows a comparative approach analyzing methionine and related metabolite and amino acid profiles using an LC-MS/MS platform in the hearts of seven mammalian species with a longevity ranging from 3.8 to 57 years. Our findings demonstrate the existence of species-specific heart phenotypes associated with high longevity characterized by: (i) low concentration of methionine and its related sulphur-containing metabolites; (ii) low amino acid pool; and (iii) low choline concentration. Our results support the existence of heart metabotypes characterized by a down-regulation in long-lived species, supporting the idea that in longevity, less is more., This work was supported by the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), the Diputació de Lleida-IRBLleida (PP10605-PIRS2021), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696)) to R.P. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The shift in the fatty acid composition of the circulating lipidome in Alzheimer's disease

  • Dakterzada, Farida
  • Jové Font, Mariona
  • Cantero, José Luís
  • Mota Martorell, Natàlia
  • Pamplona Gras, Reinald
  • Piñol Ripoll, Gerard
Introduction: Fatty acids (FAs) are the building blocks of complex lipids and signaling compounds; the role of the lipidome fatty acid profile (LFA) in AD progression remains unclear. Methods: The LFA of plasma and cerebrospinal fluid (CSF) samples from 289 participants (103 AD patients, 92 MCI patients, and 94 controls) was determined by GC-FID. The MCI subjects were followed up for 58 ± 12.5 months. Results: In controls, CSF has a more neuroprotective LFA than plasma. In CSF, a higher content of docosahexaenoic acid was associated with a reduced risk of MCI-to-AD progression. In plasma, higher oleic acid content was associated with lower risk of AD, MCI, and MCI-to-AD progression, whereas higher levels of vaccenic acid and docosahexaenoic acid were associated with greater risk of AD and MCI, and higher rate of MCI-to-AD progression, respectively. Discussion: The circulating LFA is involved in the pathogenesis and progression of AD. Highlights: The lipidome fatty acid profile in CSF and plasma was markedly different. Higher levels of vaccenic acid and lower levels of oleic acid in plasma were associated with greater risk of Alzheimer's disease. In plasma, higher levels of oleic acid were associated with a reduced risk of MCI-to-AD progression. Higher levels of docosahexaenoic acid in CSF were associated with a lower risk of MCI-to-AD progression. Higher levels of docosahexaenoic acid in plasma were associated with a greater rate of MCI-to-AD progression., Government of Catalonia,Grant/Award Number:PERIS 2019 SLT008/18/00050; Ministerio de Ciencia, Innovación y Universidades; European Union ’Awaytobuild Europe’, Grant/Award Numbers: RTI2018-099200-B-I00, PID2023-152233OB-I00; Diputació de Lleida, Grant/Award Number: PP10605-PIRS2021; Spanish Ministry of Economy and Competitiveness, Grant/Award Number: PID2020-119978RB-I00; CIBERNED, Alzheimer’s Association, Grant/Award Number:AARG-NTF-22-924702; Junta de Andalucía, Grant/Award Number: PY20_00858; Andalucía-FEDER Program, Grant/Award Number: UPO-1380913; Agency for Management of University and Research Grants, Grant/Award Number: 2021SGR 00761; Agency for Management of University and Research Grants and the European Social Fund, Grant/Award Number: FI_B100153; Agency for Management of University and Research Grants and the European Social Fund, Grant/Award Number: 2021SGR00990
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Phenotypic molecular features of long-lived animal species

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Fernández Bernal, Anna
  • Portero Otín, Manuel
  • Barja, Gustavo
  • Pamplona Gras, Reinald
One of the challenges facing science/biology today is uncovering the molecular bases that support and determine animal and human longevity. Nature, in offering a diversity of animal species that differ in longevity by more than 5 orders of magnitude, is the best ‘experimental laboratory’ to achieve this aim. Mammals, in particular, can differ by more than 200-fold in longevity. For this reason, most of the available evidence on this topic derives from comparative physiology studies. But why can human beings, for instance, reach 120 years whereas rats only last at best 4 years? How does nature change the longevity of species? Longevity is a species-specific feature resulting from an evolutionary process. Long-lived animal species, including humans, show adaptations at all levels of biological organization, from metabolites to genome, supported by signaling and regulatory networks. The structural and functional features that define a long-lived species may suggest that longevity is a programmed biological property., Research by the authors was supported by the Spanish Ministry of Science, Innovation, and Universities (grants RTI2018-099200-B-I00), the Diputació de Lleida (PP10605—PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to RP. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Plasma methionine metabolic profile is associated with longevity in mammals

  • Mota Martorell, Natàlia
  • Jové Font, Mariona
  • Berdún Hernández, Rebeca
  • Pamplona Gras, Reinald
Methionine metabolism arises as a key target to elucidate the molecular adaptations underlying animal longevity due to the negative association between longevity and methionine content. The present study follows a comparative approach to analyse plasma methionine metabolic profile using a LC-MS/MS platform from 11 mammalian species with a longevity ranging from 3.5 to 120 years. Our findings demonstrate the existence of a species-specific plasma profile for methionine metabolism associated with longevity characterised by: i) reduced methionine, cystathionine and choline; ii) increased non-polar amino acids; iii) reduced succinate and malate; and iv) increased carnitine. Our results support the existence of plasma longevity features that might respond to an optimised energetic metabolism and intracellular structures found in long-lived species., This work was supported by the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to R.P. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia. M.J. is a ‘Serra Hunter’ Fellow. N.M.M. received a predoctoral fellowship from the Generalitat of Catalonia (AGAUR, ref 2018FI_B2_00104).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease

  • Dakterzada, Farida
  • Jové Font, Mariona
  • Cantero, José Luís
  • Pamplona Gras, Reinald
Background Oxidative stress is considered to play an important role in the pathogenesis of Alzheimer's disease (AD). It has been observed that oxidative damage to specific protein targets affecting particular functional networks is one of the mechanisms by which oxidative stress contributes to neuronal failure and consequently loss of cognition and AD progression. Studies are lacking in which oxidative damage is measured at both systemic and central fluid levels and in the same cohort of patients. We aimed to determine the levels of both plasma and cerebrospinal fluid (CSF) nonenzymatic protein damage in patients in the continuum of AD and to evaluate the relation of this damage with clinical progression from mild cognitive impairment (MCI) to AD. Methods Different markers of nonenzymatic post-translational protein modification, mostly from oxidative processes, were detected and quantified in plasma and CSF by isotope dilution gas chromatography‒mass spectrometry using selected ion monitoring (SIM-GC/MS) for 289 subjects: 103 AD, 92 MCI, and 94 control subjects. Characteristics of the study population such as age, sex, Mini-mental state examination, CSF AD biomarkers, and APOE ϵ4, were also considered. Results Forty-seven (52.8%) MCI patients progressed to AD during follow-up (58 ± 12.5 months). After controlling for age, sex, and APOE ϵ4 allele, plasma and CSF concentrations of protein damage markers were not associated with either diagnosis of AD or MCI. The CSF levels of nonenzymatic protein damage markers were associated with none of the CSF AD biomarkers. In addition, neither in CSF nor in plasma were the levels of protein damage associated with the MCI to AD progression. Conclusion The lack of association between both CSF and plasma concentrations of nonenzymatic protein damage markers and AD diagnosis and progression suggests that oxidative damage in AD is a pathogenic mechanism specifically expressed at the cell-tissue level, not in extracellular fluids., This research was supported by the Government of Catalonia, Department of Health (PERIS 2019 SLT008/18/00050), and the Agency for the Management of University and Research Grants (2021SGR 00761) to GPR. The spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00 and PID2022-143140OB-I00), the Diputacio ´ de Lleida (PP10605 - PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to RP. The Spanish Ministry of Economy and Competitiveness (PID2020-119978RB-I00), CIBERNED, Alzheimer’s Association (AARG-NTF-22- 924702), the Junta de Andalucía (PY20_00858), and the AndalucíaFEDER Program (UPO-1380913) to JLC. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Caudovirales bacteriophages are associated with improved executive function and memory in flies, mice, and humans

  • Mayneris Perxachs, Jordi
  • Castells-Nobau, Anna
  • Arnoriaga Rodríguez, María
  • Garre Olmo, Josep
  • Puig, Josep
  • Ramos, Rafel
  • Martínez Hernández, Francisco
  • Burokas, Aurelijus, 1982-
  • Coll, Clàudia
  • Moreno-Navarrete, José Maria
  • Zapata-Tona, Cristina
  • Pedraza, Salvador
  • Pérez Brocal, Vicente
  • Ramió-Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Martínez García, Manuel
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
Growing evidence implicates the gut microbiome in cognition. Viruses, the most abundant life entities on the planet, are a commonly overlooked component of the gut virome, dominated by the Caudovirales and Microviridae bacteriophages. Here, we show in a discovery (n = 114) and a validation cohort (n = 942) that subjects with increased Caudovirales and Siphoviridae levels in the gut microbiome had better performance in executive processes and verbal memory. Conversely, increased Microviridae levels were linked to a greater impairment in executive abilities. Microbiota transplantation from human donors with increased specific Caudovirales (>90% from the Siphoviridae family) levels led to increased scores in the novel object recognition test in mice and up-regulated memory-promoting immediate early genes in the prefrontal cortex. Supplementation of the Drosophila diet with the 936 group of lactococcal Siphoviridae bacteriophages resulted in increased memory scores and upregulation of memory-involved brain genes. Thus, bacteriophages warrant consideration as novel actors in the microbiome-brain axis., This work was partially funded by the Instituto de Salud Carlos III (Madrid, Spain) through the project PI15/01934, PI18/01022, PI21/01361) to J.M.F.-R. and the project PI20/01090 (co-funded by the European Regional Development Fund . “A way to make Europe”) to J.M.-P., the grants SAF2015-65878-R from the Ministry of Economy and Competitiveness , Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by the Fondo Europeo de Desarrollo Regional (FEDER) funds, European Commission (FP7, NeuroPain #2013- 602891 ), the Catalan Government (AGAUR, #SGR2017-669 , #2017 SGR- 734, ICREA Academia Award 2015 to R.M. and ICREA Academia Award 2022 to J.M.F.R.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020 ), the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT), and the Project ThinkGut (EFA345/19) 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). CIBERobn is also co-funded by the European Regional Development Fund. We also acknowledge the funding from the Spanish Ministry of Science, Innovation and Universities ( RTI2018-099200-B-I00 ), and the Generalitat of Catalonia (Agency for Management of University and Research grants ( 2017SGR696 ) and Department of Health (SLT002/16/00250)) to R.M M.A.-R. is funded by the Instituto de Salud Carlos III , Río Hortega ( CM19/00190 ). J.M.-P. is funded by the Miguel Servet Program from the Instituto de Salud Carlos III ( ISCIII CP18/00009 ), co-funded by the European Social Fund “Investing in your future.” A.C.-N. is funded by the Instituto de Salud Carlos III , Sara Borrell. MMG was funded by the Spanish Ministry of Science, Innovation and Universities RTI2018-094248-B-I00.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Subjects with detectable Saccharomyces cerevisiae in the gut microbiota show deficits in attention and executive function

  • Arnoriaga Rodríguez, María
  • Mayneris Perxachs, Jordi
  • Coll, Claudia
  • Pérez Brocal, Vicente
  • Ricart, Wifredo
  • Moya, Andrés
  • Ramió Torrentà, Lluís
  • Pamplona Gras, Reinald
  • Jové Font, Mariona
  • Portero Otín, Manuel
  • Fernández Real, José Manuel
This work was partially supported by researchgrants FIS (PI15/01934 and PI18/01022) from theInstituto de Salud Carlos III from Spain, SAF2015-65878-R and RTI2018-099200-B-I00 from theMinisterio de Econom ıa y Competitividad, Prome-teo/2018/A/133 from Generalitat Valenciana,Spain, and also by Fondo Europeo de DesarrolloRegional (FEDER) funds, European Commission(FP7, NeuroPain #2013-602891), the Generalitat ofCatalunya (AGAUR, #SGR2017-669, #SGR2017-696, Department of Health SLT002/16/00250;ICREA Academia Award 2015), the Instituto deSalud Carlos III from Spain (RTA, #RD16/0017/0020) and the Fondo Europeo de DesarrolloRegional (No. 01.2.2-LMT-K-718-02-0014); andby Project ThinkGut (EFA345/19), 65% co-fi-nanced by the European Regional DevelopmentFund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). Mar ıa Arnoriaga-Rodr ıguez is funded byInstituto de Salud Calos III, R ıo Hortega (CP19/00190). Jordi Mayneris-Perxachs is funded by theMiguel Servet Program from the Instituto de SaludCarlos III (ISCIII CP18/00009), co-funded by theEuropean Social Fund “Investing in your future”.Mariona Jov e is a professor under the Serra Hunterprogramme (Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipidomic signature of stroke recurrence after transient ischemic attack

  • Purroy Garcia, Francisco
  • Ois, Ángel
  • Arque, Gloria
  • Sol, Joaquim
  • Mauri-Capdevila, Gerard
  • Rodríguez-Campello, Ana
  • Pamplona Gras, Reinald
  • Portero Otín, Manuel
  • Roquer, Jaume
While TIA patients have transient symptoms, they should not be underestimated, as they could have an underlying pathology that may lead to a subsequent stroke: stroke recurrence (SR). Previously, it has been described the involvement of lipids in different vascular diseases. The aim of the current study was to perform a lipidomic analysis to identify differences in the lipidomic profile between patients with SR and patients without. Untargeted lipidomic analysis was performed in plasma samples of 460 consecutive TIA patients recruited < 24 h after the onset of symptoms. 37 (8%) patients suffered SR at 90 days. Lipidomic profiling disclosed 7 lipid species differentially expressed between groups: 5 triacylglycerides (TG), 1 diacylglyceride (DG), and 1 alkenyl-PE (plasmalogen) [specifically, TG(56:1), TG(63:0), TG(58:2), TG(50:5), TG(53:7, DG(38:5)) and PE(P-18:0/18:2)]. 6 of these 7 lipid species belonged to the glycerolipid family and a plasmalogen, pointing to bioenergetics pathways, as well as oxidative stress response. In this context, it was proposed the PE(P-18:0/18:2) as potential biomarker of SR condition. The observed changes in lipid patterns suggest pathophysiological mechanisms associated with lipid droplets metabolism and antioxidant protection that is translated to plasma level as consequence of a more intensive or high-risk ischemic condition related to SR., Tis study was supported by the Government of Catalonia-Agència de Gestió d’Ajuts Universitaris i de Recerca (FP: 2017SGR1628 and 2021SGR01479; RP: 2021SGR00990); Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF, "Investing in your future" and "A way to build Europe") (FP: PI17-01725, PI14/01574; M.P-O: PI 17-00134, 20-0155); the Spanish Ministry of Science, Innovation and Universities (RP: RTI2018-099200-B-I00 and PID2022-143140OB-I00); the Department of Health (RP: SLT002/16/00250); and the INVICTUS plus Research Network (Carlos III Health Institute) (FP, CT and GA: RD16-0019-0017; TS: RD16-0019-0012; AO and JR: RD16-0019-0012; AC: RD16-0019-0006. M.J. is a professor under the Serra Hunter program (Generalitat de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

mTOR Complex 1 Content and Regulation Is Adapted to Animal Longevity

  • Mota Martorell, Natàlia
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Decreased content and activity of the mechanistic target of rapamycin (mTOR) signalling pathway, as well as the mTOR complex 1 (mTORC1) itself, are key traits for animal species and human longevity. Since mTORC1 acts as a master regulator of intracellular metabolism, it is respon sible, at least in part, for the longevous phenotype. Conversely, increased content and activity of mTOR signalling and mTORC1 are hallmarks of ageing. Additionally, constitutive and aberrant activity of mTORC1 is also found in age-related diseases such as Alzheimer’s disease (AD) and cancer. The downstream processes regulated through this network are diverse, and depend upon nutrient availability. Hence, multiple nutritional strategies capable of regulating mTORC1 activity and, consequently, delaying the ageing process and the development of age-related diseases, are under continuous study. Among these, the restriction of calories is still the most studied and ro bust intervention capable of downregulating mTOR signalling and feasible for application in the human population., Research by the authors was supported by the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, co-financed by FEDER funds from the European Union ‘A way to build Europe’, grant RTI2018-099200-B-I00), the IRBLleida-Diputació de Lleida (PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696) to R.P. IRBLleida is a CERCA Programme/Generalitat of Catalonia
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Manipulating mtDNA in vivo reprograms metabolism via novel response mechanisms

  • Bahhir, Diana
  • Yalgin, Cagri
  • Ots, Liina
  • Järvinen, Sampsa
  • George, Jack
  • Naudí i Farré, Alba
  • Krama, Tatjana
  • Krams, Indrikis
  • Tamm, Mairi
  • Andjelković, Ana
  • Dufour, Eric
  • González de Cosar, Jose M.
  • Gerards, Mike
  • Parhiala, Mikael
  • Pamplona Gras, Reinald
  • Jacobs, Howard T.
  • Jõers, Priit
Mitochondria have been increasingly recognized as a central regulatory nexus for multiple metabolic pathways, in addition to ATP production via oxidative phosphorylation (OXPHOS). Here we show that inducing mitochondrial DNA (mtDNA) stress in Drosophila using a mitochondrially-targeted Type I restriction endonuclease (mtEcoBI) results in unexpected metabolic reprogramming in adult flies, distinct from effects on OXPHOS. Carbohydrate utilization was repressed, with catabolism shifted towards lipid oxidation, accompanied by elevated serine synthesis. Cleavage and translocation, the two modes of mtEcoBI action, repressed carbohydrate rmetabolism via two different mechanisms. DNA cleavage activity induced a type II diabetes-like phenotype involving deactivation of Akt kinase and inhibition of pyruvate dehydrogenase, whilst translocation decreased post-translational protein acetylation by cytonuclear depletion of acetyl-CoA (AcCoA). The associated decrease in the concentrations of ketogenic amino acids also produced downstream effects on physiology and behavior, attributable to decreased neurotransmitter levels. We thus provide evidence for novel signaling pathways connecting mtDNA to metabolism, distinct from its role in supporting OXPHOS., This work was supported by following grants: Academy of Finland postdoctoral grant nr. 132997 and exploratory research grant nr. PUT573 from Estonian Research Council to Priit Jõers; Academy Professorship (255365) and Centre of Excellence grants (272376 and 307431) by Academy of Finland to Howard T Jacobs; Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), the Generalitat of Catalonia, Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250), and by FEDER funds from European Union (“A way to build Europe”) to Reinald Pamplona; Vilho Rossin Fund (Finnish Cultural Foundation) grant to Ana Andjelković; Estonian Research Council grant nr. PUT1223 and Latvian Council of Science grant nr. lzp-2018/1-0393 to Indrikis Krams, IUT36-2 to Tatjana Krama; and AFM grant nr. 17424 to Eric Dufour. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Metabolomics reveals that fittest trail runners show a better adaptation of bioenergetic pathways

  • Puigarnau Coma, Sílvia
  • Fernàndez, Anna
  • Obis Monné, Èlia
  • Jové Font, Mariona
  • Castañer Balcells, Marta
  • Pamplona Gras, Reinald
  • Portero Otín, Manuel
  • Camerino Foguet, Oleguer
Objectives: To analyze the effect in the blood metabolome of trail running, a demanding sport that takes place in the natural environment, places considerable strain on both muscles and joints. While metabolic responses to aerobic exercise have been analyzed in-depth, few studies have focused on trail running. Design: Observational study to analyze changes in 35 different metabolites - representative of aerobic exercise- induced by a simulated 21-km trail race with an uphill gradient of 1400 m. Methods: We performed a semiquantitative metabolomics study consisting of capillary blood microsampling and targeted screening with liquid chromatography and mass spectrometry to analyze, in 33 licensed athletes, changes concerning 35 metabolites. Results: We observed significant changes in many metabolites, including increased acetyl-carnitine and taurine concentrations (false discovery rate–corrected paired t-test P value 1.63 × 10–13, and P value 5.021 × 10-12, re- spectively) and decreased carnitine and proline concentrations (P value 6.33 × 10–10, and P value 1.21 × 10–9, re- spectively). Metabolic responses to trail running were largely independent of sex but were influenced by the level of training, with runners with a higher level showing resistance to exercise-induced changes in taurine, 1-methyl histidine, acetyl-carnitine, and hypoxanthine concentrations. Performance (measured as race time) was inversely correlated with changes in specific metabolites (including taurine, serotonin, and hypoxanthine) and directly correlated with increases in glutathione. Conclusions: Our findings demonstrate the usefulness of metabolomics studies for analyzing exercise-induced physiological changes and show individual differences associated with the level of training and performance., This work was supported by the Generalitat de Catalunya, Agency for Management of University and Research Grants [2017SGR696]; by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III [PI17-00134 and PI20-00155]; and by the Spanish Ministry of Science, Innovation and Universities [RTI2018-099200-B-I00]. MJ is a Serra-Hunter program fellow. AF is a fellow of Banco de Santander-UdL predoctoral program. We are also grateful for the support of; the National Institute of Physical Education of Catalonia (INEFC); and the Spanish government subproject Integration ways between qualitative and quantitative data, multiple case development, and synthesis review as main axis for an innovative future in physical activity and sports research [PGC2018-098742-B-C31] (2019–2021) (Ministry of Science, Innovation and Universities/Spanish State Research Agency/European Regional Development Fund), that is part of the coordinated project New approach of research in physical activity and sport from mixed methods perspective (NARPAS_MM) [SPGC201800X098742CV0]; and the Generalitat de Catalunya Research Group [Research group and innovation in designs] (GRID). Technology and multimedia and digital application to observational designs [Grant number 2017 SGR 1405]. FEDER funds are acknowledged [“A way to build Europe”].
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Alterations in one-carbon metabolism in celiac disease

  • Martin-Masot, Rafael
  • Mota Martorell, Natàlia
  • Jové Font, Mariona
  • Maldonado, José
  • Pamplona Gras, Reinald
  • Nestares, Teresa
Celiac disease (CD) is an autoimmune enteropathy associated with alterations of metabolism. Metabolomics studies, although limited, showed changes in choline, choline-derived lipids, and methionine concentrations, which could be ascribed to alterations in one-carbon metabolism. To date, no targeted metabolomics analysis investigating differences in the plasma choline/methionine metabolome of CD subjects are reported. This work is a targeted metabolomic study that analyzes 37 metabolites of the one-carbon metabolism in 17 children with CD, treated with a gluten-free diet and 17 healthy control siblings, in order to establish the potential defects in this metabolic network. Our results demonstrate the persistence of defects in the transsulfuration pathway of CD subjects, despite dietary treatment, while choline metabolism, methionine cycle, and folate cycle seem to be reversed and preserved to healthy levels. These findings describe for the first time, a metabolic defect in one-carbon metabolism which could have profound implications in the physiopathology and treatment of CD., This research was funded by the Regional Government of Andalusia, Excellence Research Project No P12-AGR-2581, the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-BI00), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696), and Department of Health (SLT002/16/00250) to RP. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia. It was also partially funded with the grant “Investigation grant program by the SPAO” 2020 edition
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer's disease

  • Dakterzada, Farida
  • Jové Font, Mariona
  • Huerto Vilas, Raquel
  • Carnes Vendrell, Anna
  • Sol, Joaquim
  • Pamplona Gras, Reinald
  • Piñol Ripoll, Gerard
Genetic, metabolic, and clinical evidence links lipid dysregulation to an increased risk of Alzheimer's disease (AD). However, the role of lipids in the pathophysiological processes of AD and its clinical progression is unclear. We investigated the association between cerebrospinal fluid (CSF) lipidome and the pathological hallmarks of AD, progression from mild cognitive impairment (MCI) to AD, and the rate of cognitive decline in MCI patients. The CSF lipidome was analyzed by liquid chromatography coupled to mass spectrometry in an LC-ESI-QTOF-MS/MS platform for 209 participants: 91 AD, 92 MCI, and 26 control participants. The MCI patients were followed up for a median of 58 (± 12.5) months to evaluate their clinical progression to AD. Forty-eight (52.2%) MCI patients progressed to AD during follow-up. We found that higher CSF levels of hexacosanoic acid and ceramide Cer(d38:4) were associated with an increased risk of amyloid beta 42 (Aβ42) positivity in CSF, while levels of phosphatidylethanolamine PE(40:0) were associated with a reduced risk. Higher CSF levels of sphingomyelin SM(30:1) were positively associated with pathological levels of phosphorylated tau in CSF. Cholesteryl ester CE(11D3:1) and an unknown lipid were recognized as the most associated lipid species with MCI to AD progression. Furthermore, TG(O-52:2) was identified as the lipid most strongly associated with the rate of progression. Our results indicate the involvement of membrane and intracellular neutral lipids in the pathophysiological processes of AD and the progression from MCI to AD dementia. Therefore, CSF neutral lipids can be used as potential prognostic markers for AD., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. Government of Catalonia, Department of Health (PERIS 2019 SLT008/18/00050), and the Agency for the Management of University and Research Grants (2021SGR00761) to GPR. The Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades), cof inanced by FEDER funds from the European Union “A way to build Europe” (grant RTI2018-099200-B-I00), the IRBLleidaDiputació de Lleida (PP10605-PIRS2021), and the Government of Catalonia: Agency for the Management of University and Research Grants (2021SGR00990) to RP. IRBLleida is a CERCA Programme of the Government of Catalonia
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Low abundance of NDUFV2 and NDUFS4 subunits of the hydrophilic complex I domain and VDAC1 predicts mammalian longevity

  • Mota Martorell, Natàlia
  • Jové Font, Mariona
  • Pradas Barriga, Irene
  • Sanchez, Isabel
  • Gómez, José
  • Naudí i Farré, Alba
  • Barja, Gustavo
  • Pamplona Gras, Reinald
Mitochondrial reactive oxygen species (ROS) production, specifically at complex I (Cx I), has been widely suggested to be one of the determinants of species longevity. The present study follows a comparative approach to analyse complex I in heart tissue from 8 mammalian species with a longevity ranging from 3.5 to 46 years. Gene expression and protein content of selected Cx I subunits were analysed using droplet digital PCR (ddPCR) and western blot, respectively. Our results demonstrate: 1) the existence of species-specific differences in gene expression and protein content of Cx I in relation to longevity; 2) the achievement of a longevity phenotype is associated with low protein abundance of subunits NDUFV2 and NDUFS4 from the matrix hydrophilic domain of Cx I; and 3) long-lived mammals show also lower levels of VDAC (voltage-dependent anion channel) amount. These differences could be associated with the lower mitochondrial ROS production and slower aging rate of long-lived animals and, unexpectedly, with a low content of the mitochondrial permeability transition pore in these species., This work was supported by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (grant number PI14/00328), the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia, Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to R.P, and PR [19] BIO MET 0155 to GB.This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Long-lived Humans Have a Unique Plasma Sphingolipidome

  • Pradas Barriga, Irene
  • Jové Font, Mariona
  • Huynh, Kevin
  • Inglés, Marta
  • Borrás, Consuelo
  • Mota Martorell, Natàlia
  • Galo-Licona, José Daniel
  • Puig, Josep
  • Viña Ribes, José
  • Meikle, Peter J.
  • Pamplona Gras, Reinald
A species-specific lipidome profile is an inherent feature linked to longevity in the animal kingdom. However, there is a lack of lipidomic studies on human longevity. Here, we use mass spectrometry-based lipidomics to detect and quantify 151 sphingolipid molecular species and use these to define a phenotype of healthy humans with exceptional life span. Our results demonstrate that this profile specifically comprises a higher content of complex glycosphingolipids (hexosylceramides and gangliosides), and lower levels of ceramide species from the de novo pathway, sphingomyelin and sulfatide; while for ceramide-derived signaling compounds, their content remains unchanged. Our findings suggest that structural glycosphingolipids may be more relevant to achieve the centenarian condition than signaling sphingolipids., We acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00) and the Generalitat of Catalonia, Agency for management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to R.P., and Spanish Ministry of Education and Science (SAF2013-44663-R) and the ‘Red Tematica de Investigación Cooperativa en Envejecimiento y Fragilidad’ (RETICEF) (ISCIII2012-RED-43-029) to J.V. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). I.P. was supported by a University of Lleida Predoctoral Fellowship. K.H. was supported by a Dementia Australia Research Foundation Scholarship.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease

  • Dakterzada, Farida
  • Jové Font, Mariona
  • Huerto Vilas, Raquel
  • Carnes Vendrell, Anna
  • Sol, Joaquim
  • Pamplona Gras, Reinald
  • Piñol Ripoll, Gerard
Aberrant lipid metabolism has been strongly linked to Alzheimer’s disease (AD) pathogenesis. However, the role of lipids in the pathophysiological processes of AD and their clinical progression is unclear. We hypothesized that plasma lipids are associated with the pathological hallmarks of AD, progression from mild cognitive impairment (MCI) to AD, and the rate of cognitive decline in MCI patients. To evaluate our hypotheses, we analysed the plasma lipidome profile by liquid chromatography coupled to mass spectrometry in an LC-ESI-QTOF-MS/MS platform for 213 subjects recruited consecutively: 104 AD, 89 MCI, and 20 control subjects. Forty-seven (52.8%) MCI patients progressed to AD during follow-up (58 ± 12.5 months). We found that higher plasma levels of sphingomyelin SM(36:0) and diglyceride DG(44:3) were associated with an increased risk of amyloid beta 42 (Aβ42) positivity in CSF, while levels of SM(40:1) were associated with a reduced risk. Higher plasma levels of ether-linked triglyceride TG(O-60:10) were negatively associated with pathological levels of phosphorylated tau in CSF. Plasma levels of fatty acid ester of hydroxy fatty acid FAHFA(34:0) and ether-linked phosphatidylcholine PC(O-36:1) were positively associated with pathological levels of total tau in CSF. Regarding the plasma lipids most associated with progression from MCI to AD, our analysis detected phosphatidyl-ethanolamine plasmalogen PE(P-36:4), TG(59:12), TG(46:0), and TG(O-62:7). Furthermore, TG(O-62:7) was the lipid that was most strongly associated with the rate of progression. In conclusion, our results indicate that neutral and ether-linked lipids are involved in the pathophysiological processes of AD and the progression from MCI to AD dementia, suggesting the involvement of lipid-mediated antioxidant mechanisms in AD., We would like to express our sincere gratitude to all of the patients and all of the members of the dementia unit at the Hospital Universitari Santa Maria. Mariona Jové is a ‘Serra-Hunter’ Fellow. Farida Dakterzada was supported by the Agency for Management of University and Research Grants and the European Social Fund (FI_B100153). The Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (PI22/01687) and Agency for Management of University and Research Grants (2021SGR00761) to Gerard Piñol-Ripoll. The Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades) (grant RTI2018-099200-B-I00 and PID2022-143140- OB-I00), the IRBLleida-Diputació de Lleida (PP10605- PIRS2021), and the Government of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) to Reinald Pamplona. This study was co-financed by FEDER funds from the European Union 'A way to build Europe'. IRBLleida is a CERCA Program of the Government of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The Causal Role of Lipoxidative Damage in Mitochondrial Bioenergetic Dysfunction Linked to Alzheimer's Disease Pathology

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Torres Cabestany, Pascual
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Portero Otín, Manuel
  • Ferrer, Isidre
  • Pamplona Gras, Reinald
Current shreds of evidence point to the entorhinal cortex (EC) as the origin of the Alzheimer’s disease (AD) pathology in the cerebrum. Compared with other cortical areas, the neurons from this brain region possess an inherent selective vulnerability derived from particular oxidative stress conditions that favor increased mitochondrial molecular damage with early bioenergetic involvement. This alteration of energy metabolism is the starting point for subsequent changes in a multitude of cell mechanisms, leading to neuronal dysfunction and, ultimately, cell death. These events are induced by changes that come with age, creating the substrate for the alteration of several neuronal pathways that will evolve toward neurodegeneration and, consequently, the development of AD pathology. In this context, the present review will focus on description of the biological mechanisms that confer vulnerability specifically to neurons of the entorhinal cortex, the changes induced by the aging process in this brain region, and the alterations at the mitochondrial level as the earliest mechanism for the development of AD pathology. Current findings allow us to propose the existence of an altered allostatic mechanism at the entorhinal cortex whose core is made up of mitochondrial oxidative stress, lipid metabolism, and energy production, and which, in a positive loop, evolves to neurodegeneration, laying the basis for the onset and progression of AD pathology., Research by the authors was supported by the Institute of Health Carlos III (FIS grantsPI14/00757, PI14/00328, PI20/0155), the Spanish Ministry of Science, Innovation, and Universities(Ministerio de Ciencia, Innovación y Universidades, grant RTI2018-099200-B-I00), and the Generalitatof Catalonia: Agency for Management of University and Research Grants (2017SGR696) to M.P-O.,I.F., and R.P. This study was co-financed by FEDER funds from the European Union (‘A way tobuild Europe’).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Selective brain regional changes in lipid profile with human aging

  • Mota Martorell, Natàlia
  • Andrés Benito, Pol
  • Martín Garí, Meritxell
  • Galo-Licona, José Daniel
  • Sol, Joaquim
  • Fernández Bernal, Anna
  • Portero Otín, Manuel
  • Ferrer, Isidre
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Fatty acids are key components in the structural diversity of lipids and play a strategic role in the functional properties of lipids which determine the integrity of neuronal and glial cell membranes, the generation of lipid signaling mediators, and the chemical reactivity of acyl chains. The present study analyzes using gas chromatography the fatty acid profiles of 13 regions of the human central nervous system in healthy individuals ranging from 40 to 80 years old. The outcomes suggest the existence of general traits in fatty acid composition such as an average chain length of 18 carbon atoms, high monounsaturated fatty acid content, and predominance in polyunsaturated fatty acids of those of series n-6 over series n-3 which are shared by all brain regions regardless of age. Our results also show a general sustained and relatively well-preserved lipid profile throughout the adult lifespan in most studied regions (olive, upper vermis, substantia nigra, thalamus, hippocampus, putamen, caudate, occipital cortex, parietal cortex, entorhinal cortex, and frontal cortex) with minor changes that are region-dependent. In contrast, of particular relevance is the involvement of the inferior temporal cortex and cingulate cortex. It is proposed that during normal human brain aging, the lipid profile is resistant to changes with age in most human brain regions to ensure cell survival and function, but some particular regions involved in specific memory domains are greatly affected., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This research was funded by the Spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00), the IRBLleida-Dipuatació de Lleida (PIRS2021), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696) to R.P. This study was cofnanced by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women

  • Pradas Barriga, Irene
  • Rovira-Llopis, Susana
  • Naudí i Farré, Alba
  • Bañuls, Celia
  • Rocha, Milagros
  • Hernández-Mijares, Antonio
  • Pamplona Gras, Reinald
  • Victor, Victor M.
  • Jové Font, Mariona
Metformin is one of the treatments used for pcoS pathology decreasing body weight, plasma androgen, FSH and glucose levels. Unfortunately, there is little known about metformin’s effects on lipid metabolism, a crucial process in pcoS pathology. We have employed a lipidomic approach to explore alterations in the plasma lipid profile of patients with PCOS following metformin treatment. The aim is to offer new insights about the effect of metformin in PCOS patients. Plasma samples were obtained from 27 subjects prior to and following 12 weeks of metformin treatment. A detailed biochemical characterization and lipidomic profile was performed. Metformin reduces BMI, HOMA-IR, fSH and androstenedione and increases DHeA-S but no changes were found in glucose levels after treatment. Multivariate statistics revealed a specific lipidomic signature due to the effect of 12 weeks of metformin treatment in pcoS patients. this signature includes changes in sphingolipid metabolism suggesting a crosstalk between these lipid species and the androgenic metabolism and a decrease in oxidized lipids reinforcing that metformin treatment improves oxidative stress status. our study confirms the specific effect of metformin in lipid metabolism on women with PCOS after 12 weeks of treatment., We thank Maria Rosa Gomez and David Argiles for technical support. This research was funded by grants from Carlos III Health Institute (ISCIII) (PI16/1083, PI16/0301) to V.M.V and M.R, respectively and CIBERehd (CB06/04/0071)−initiatives of the ISCIII to M.R and V.M.V, the European Regional Development Fund (ERDF “A way to build Europe”). Unrestricted grant from Menarini S.A to M.R. V.M.V. and M.R. are recipients of contracts from the Ministry of Health of the Valencian Regional Government and Carlos III Health Institute (CES10/030 and CP10/0360, respectively). R. P. is recipient of contracts from the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (grant number PI14/00328); Spanish Ministry of Science, Innovation and Universities (grant number RTI2018-099200-B-I00), and the Generalitat of Catalonia, Department of Health (grant number SLT002/16/00250) and Department of Business and Knowledge (grant number 2017SGR696). This study has been co-financed by FEDER funds from the European Union (‘A way to build Europe’). I.P. received a predoctoral fellowship from the Lleida University. S.R-LL. is recipient of a Juan de la Cierva contract from Spanish Ministry of Economy and Competitiveness (FJCI-2015-25040). C.B. is recipient of a Sara Borrell contract from Institute of Health Carlos III (CD14/00043). M.J is a Serra Húnter Fellow.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Plasma acylcarnitines and gut-derived aromatic amino acids as sex-specific hub metabolites of the human aging metabolome

  • Sol, Joaquim
  • Obis Monné, Èlia
  • Mota Martorell, Natàlia
  • Pradas Barriga, Irene
  • Galo-Licona, José Daniel
  • Martín Garí, Meritxell
  • Fernández Bernal, Anna
  • Ortega Bravo, Marta
  • Mayneris Perxachs, Jordi
  • Borrás, Consuelo
  • Viña Ribes, José
  • Fuente, Monica de la
  • Mate, Ianire
  • Biarnés, Carles
  • Pedraza, Salvador
  • Vilanova, Joan Carles
  • Brugada, Ramon
  • Ramos, Rafel
  • Serena, Joaquín
  • Ramió Torrentà, Lluís
  • Pineda, Víctor
  • Daunis-i-Estadella, Pepus
  • Thió-Henestrosa, Santiago
  • Barretina Ginesta, Jordi
  • Garre Olmo, Josep
  • Portero Otín, Manuel
  • Fernández Real, José Manuel
  • Puig, Josep
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Aging biology entails a cell/tissue deregulated metabolism that affects all levels of biological organization. Therefore, the application of “omic” techniques that are closer to phenotype, such as metabolomics, to the study of the aging process should be a turning point in the definition of cellular processes involved. The main objective of the present study was to describe the changes in plasma metabolome associated with biological aging and the role of sex in the metabolic regulation during aging. A high-throughput untargeted metabolomic analysis was applied in plasma samples to detect hub metabolites and biomarkers of aging incorporating a sex/gender perspective. A cohort of 1030 healthy human adults (45.9% females, and 54.1% males) from 50 to 98 years of age was used. Results were validated using two independent cohorts (1: n = 146, 53% females, 30–100 years old; 2: n = 68, 70% females, 19–107 years old). Metabolites related to lipid and aromatic amino acid (AAA) metabolisms arose as the main metabolic pathways affected by age, with a high influence of sex. Globally, we describe changes in bioenergetic pathways that point to a decrease in mitochondrial β-oxidation and an accumulation of unsaturated fatty acids and acylcarnitines that could be responsible for the increment of oxidative damage and inflammation characteristic of this physiological process. Furthermore, we describe for the first time the importance of gut-derived AAA catabolites in the aging process describing novel biomarkers that could contribute to better understand this physiological process but also age-related diseases., This research was funded by the Spanish Ministry of Science,Innovation, and Universities (grant RTI2018-099200-B- I00, and PID2022-143140OB-I00, co-funded by the European Regional Development Fund. “A way to build Europe”), and the Generalitat of Catalonia (Agency for Management of University and Research Grants [2021SGR00990] and Department of Health [SLT002/16/00250])to R.P. The work is also supported by “la Caixa” Foundation (Grant Agreement LCF/PR/HR21/52410002) to M.J. IRBLleida is a CERCAProgramme/Generalitat of Catalonia. This work was also partiallysupported by Instituto de Salud Carlos III (Madrid, Spain) through the research grants PI15/01934, PI18/01022, PI20/01090, and PI21/01361 (co-funded by the European Regional Development Fund. “A way to make Europe”), and the Catalan Government (AGAUR,#SGR2017-0734, ICREA Academia Award 2021) to J.M.F-R.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Age-Related Changes in Lipidome of Rat Frontal Cortex and Cerebellum Are Partially Reversed by Methionine Restriction Applied in Old Age

  • Jové Font, Mariona
  • Cabré, Rosanna
  • Mota Martorell, Natàlia
  • Martín Garí, Meritxell
  • Obis Monné, Èlia
  • Ramos, Paula
  • Canales , Iván
  • Galo-Licona, José Daniel
  • Sol, Joaquim
  • Nogueras Penabad, Lara
  • Torres Cabestany, Pascual
  • Portero Otín, Manuel
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Ferrer, Isidre
  • Pamplona Gras, Reinald
Lipids are closely associated with brain structure and function. However, the potential changes in the lipidome induced by aging remain to be elucidated. In this study, we used chromatographic techniques and a mass spectrometry-based approach to evaluate age-associated changes in the lipidome of the frontal cortex and cerebellum obtained from adult male Wistar rats (8 months), aged male Wistar rats (26 months), and aged male Wistar rats submitted to a methionine restriction diet (MetR) as an anti-aging intervention for 8 weeks. The outcomes revealed that only small changes (about 10%) were observed in the lipidome profile in the cerebellum and frontal cortex during aging, and these changes differed, in some cases, between regions. Furthermore, a MetR diet partially reversed the effects of the aging process. Remarkably, the most affected lipid classes were ether-triacylglycerols, diacylglycerols, phosphatidylethanolamine N-methylated, plasmalogens, ceramides, and cholesterol esters. When the fatty acid profile was analyzed, we observed that the frontal cortex is highly preserved during aging and maintained under MetR, whereas in the cerebellum minor changes (increased monounsaturated and decreased polyunsaturated contents) were observed and not reversed by MetR. We conclude that the rat cerebellum and frontal cortex have efficient mechanisms to preserve the lipid profile of their cell membranes throughout their adult lifespan in order to maintain brain structure and function. A part of the small changes that take place during aging can be reversed with a MetR diet applied in old age., This research was funded by the Spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696) to R.P.; and from Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI20-0155) to M.P.-O. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment

  • Andrés Benito, Pol
  • Gelpí, Ellen
  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Obis Monné, Èlia
  • Portero Otín, Manuel
  • Povedano, Mònica
  • Pujol, Aurora
  • Pamplona Gras, Reinald
  • Ferrer, Isidre
Aim. Peroxisomes play a key role in lipid metabolism, and peroxisome defects have been associated with neurodegenerative diseases such as X-adrenoleukodystrophy and Alzheimer's disease. This study aims to elucidate the contribution of peroxisomes in lipid alterations of area 8 of the frontal cortex in the spectrum of TDP43-proteinopathies. Cases of frontotemporal lobar degeneration-TDP43 (FTLD-TDP), manifested as sporadic (sFTLD-TDP) or linked to mutations in various genes including expansions of the non-coding region of C9ORF72 (c9FTLD), and of sporadic amyotrophic lateral sclerosis (sALS) as the most common TDP43 proteinopathies, were analysed. Methods. We used transcriptomics and lipidomics methods to define the steady-state levels of gene expression and lipid profiles. Results. Our results show alterations in gene expression of some components of peroxisomes and related lipid pathways in frontal cortex area 8 in sALS, sFTLD-TDP and c9FTLD. Additionally, we identify a lipidomic pattern associated with the ALS-FTLD-TDP43 proteinopathy spectrum, notably characterised by down-regulation of ether lipids and acylcarnitine among other lipid species, as well as alterations in the lipidome of each phenotype of TDP43 proteinopathy, which reveals commonalities and disease-dependent differences in lipid composition. Conclusion. Globally, lipid alterations in the human frontal cortex of the ALS-FTLD-TDP43 proteinopathy spectrum, which involve cell membrane composition and signalling, vulnerability against cellular stress and possible glucose metabolism, are partly related to peroxisome impairment., Research by the authors was supported by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI 17–00134) to M.P-O; the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (FIS grants FISPI17/000809) to IF; and by the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-BI00) and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to RP. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). Support was also received in the form of a FUNDELA Grant, RedELA-Plataforma Investigación and the Fundació Miquel Valls (Jack Van den Hoek donation). IRBLleida and IDIBELL are CERCA Programmes of the Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipid Adaptations against Oxidative Challenge in the Healthy Adult Human Brain

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Obis Monné, Èlia
  • Sol, Joaquim
  • Martín Garí, Meritxell
  • Ferrer, Isidre
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
It is assumed that the human brain is especially susceptible to oxidative stress, based on specific traits such as a higher rate of mitochondrial free radical production, a high content in peroxidizable fatty acids, and a low antioxidant defense. However, it is also evident that human neurons, although they are post-mitotic cells, survive throughout an entire lifetime. Therefore, to reduce or avoid the impact of oxidative stress on neuron functionality and survival, they must have evolved several adaptive mechanisms to cope with the deleterious effects of oxidative stress. Several of these antioxidant features are derived from lipid adaptations. At least six lipid adaptations against oxidative challenge in the healthy human brain can be discerned. In this work, we explore the idea that neurons and, by extension, the human brain is endowed with an important arsenal of non-pro-oxidant and antioxidant measures to preserve neuronal function, refuting part of the initial premise., Research by the authors was supported by the Spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00), the Diputació de Lleida (PP10605-PIRS2021), the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696), and Department of Health (SLT002/16/00250) to RP. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cognitive Training with Modern Board and Card Games in Healthy Older Adults: Two Randomized Controlled Trials

  • Estrada Plana, Verónica
  • Montanera, Roger
  • Ibarz Estruga, Ana
  • March Llanes, Jaume
  • Vita Barrull, Núria
  • Guzmán, Núria
  • Ros Morente, Agnès
  • Ayesa, Rosa
  • Moya Higueras, Jorge
Objectives. The aim of this study was to assess the effectiveness of a cognitive intervention based on modern board and card games. Methods. We conducted two two-arm parallel-group, randomized controlled trials. The first one (pilot study) was non-blind. The second one (main study) was a doubleblind design. Participants (14 in a pilot study and 35 in the main study) were healthy older adults over 65 years old who were assisting to adult care institutions. In the pilot study, participants in the experimental group (n=6) played modern board and card games which activated cognitive processes; whereas the control group (n=6) was in the wait-list condition. In the main study, participants in the experimental group (n=12) also played modern board and card games; whereas the control group (n=15) performed standardized paper-and-pencil cognitive tasks. Psychologists specialized in older-people conducted all the interventions. In both studies, intervention sessions were bi-weekly for 5 weeks. The outcomes of both studies were cognitive status and executive functioning, depressive symptomatology, and quality of life measures. All assessment and intervention sessions took place in their habitual centers. Results. In the pilot study, participants in the games intervention showed a significant improvement in semantic verbal fluency. In the main study, both interventions showed significant improvements in phonemic verbal fluency. Whilst board and card games maintained motor impulsivity control, paper-and-pencil tasks improved speed in an inhibition task. Conclusions. Modern board and card games could be an effective cognitive intervention to maintain some cognitive functions., We would like to express our gratitude to the participants, the centers (Balàfia I and II, and Comtes Urgell) and all their workers. Thanks to the Comissionat per a Universitats i Recerca del DIUE, Generalitat de Catalunya (2017SGR1577), to the Center for Biomedical Research Network on Mental Health (CIBERSAM), and to Spanish Ministry of Science, Innovation and Universities (MICIU/FEDER; project RTI2018‐099800‐B‐I00).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Prevalence and Predictors of Cerebral Microangiopathy Determined by Pulsatility Index in an Asymptomatic Population From the ILERVAS Project

  • Purroy Garcia, Francisco
  • Sánchez Peña, Enric
  • Lecube Torelló, Albert
  • Arque, Gloria
  • Vicente-Pascual, Mikel
  • Mauri-Capdevila, Gerard
  • Torreguitart, Núria
  • Hernández García, Marta
  • Barbé Illa, Ferran
  • Fernández i Giráldez, Elvira
  • Pamplona Gras, Reinald
  • Farràs-Sallés, Cristina
  • Mauricio Puente, Dídac
  • Bermúdez López, Marcelino
Background: Little is known about the prevalence of cerebral microangiopathy (CM), which is related to cognitive impairment, in an asymptomatic population. Pulsatility index (PI) is an easily measurable parameter of cerebral vascular resistance in transcranial duplex of the middle cerebral artery (MCA) study. We aimed to determine the prevalence of CM measured by PI of MCA in low to moderate vascular risk subjects. Methods: We included 3,721 subjects between 45 and 70 years without previous history of vascular disease or diabetes mellitus and with at least one other vascular risk factor from the cross-sectional study ILERVAS (Lleida, Spain). Patients underwent transcranial duplex to determine MCA-PI. Possible CM was defined by MCA-PI >1.1. Carotid and femoral arteries ultrasound registration was done to determine the presence, the number, and the area of atheromatous plaques. Body mass index (BMI), pulse pressure (PP) and laboratory data were also recorded. Results: 439 (11.8%) subjects were excluded due to the low quality of transcranial duplex images. Median age was 57 [IQR 52, 62] years. Possible CM was found in 424 (12.9%) subjects. CM patients had higher prevalence of plaques than non-CM (77.4 vs. 66.4%, p < 0.001). PI showed a positive linear correlation with the number of territories with plaques (r = 0.130, p < 0.001), and the total plaque area (r = 0.082, p < 0.001). The predictors of possible CM were the age, male gender, and PP. Conclusions: In low-to-moderate vascular risk asymptomatic population, the proportion of abnormal brain microvascular bed determined by MCA-PI is not negligible. The planned 10-year follow-up will describe the clinical relevance of these findings., This work was supported by grants from the Diputacio de Lleida, Instituto de Salud Carlos III (RETIC RD16/0009/0011) and Ministerio de Ciencia, Inovación y Universidades (IJC2018-037792-I). FP was supported by the Catalan Autonomous Government’s Agència de Gestió d’Ajuts Universitaris i de Recerca (2017 suport a les activitats dels grups de recerca 1628). RP was supported by the Spanish Ministry of Science, Innovation, and Universities (grant RTI2018-099200-B-I00), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696). This study was co-financed by FEDER funds from the European Union (A way to build Europe). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gene expression and regulatory factors of the mechanistic target of rapamycin (mTOR) complex 1 predict mammalian longevity, mTORC1 and longevit

  • Mota Martorell, Natàlia
  • Jové Font, Mariona
  • Pradas Barriga, Irene
  • Berdún Hernández, Rebeca
  • Sanchez, Isabel
  • Naudí i Farré, Alba
  • Garí Marsol, Eloi
  • Barja, Gustavo
  • Pamplona Gras, Reinald
Maximum longevity (ML) varies significantly across animal species, but the underlying molecular mechanisms remain poorly understood. Recent studies and omics approaches suggest that phenotypic traits of ML could to converge in the mammalian target of rapamycin (mTOR) signalling pathway. The present study is a comparative approach using heart tissue from 8 mammalian species with a ML ranging from 3.5 to 46 years. Gene expression, protein content, and concentration of regulatory metabolites of the mTOR complex 1 (mTORC1) were measured using droplet digital PCR, western blot and mass spectrometry, respectively. Our results demonstrate 1) the existence of differences species-specific in gene expression and protein content of mTORC1; 2) that the achievement of a longevity phenotype requires decreased and inhibited mTORC1; 3) decreased content of mTORC1 activators in long-lived animals, and 4) independence of phylogeny relationships on these changes. Altogether, our findings support mTORC1 down-regulation to achieve a longevous phenotype., This work was supported by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (grant number PI14/00328), the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia, Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to R.P. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Elovl2-Ablation Leads to Mitochondrial Membrane Fatty Acid Remodeling and Reduced Efficiency in Mouse Liver Mitochondria

  • Gómez Rodríguez, Alexia
  • Talamonti, Emanuela
  • Naudí i Farré, Alba
  • Kalinovich, Anastasia V.
  • Pauter, Anna M.
  • Barja, Gustavo
  • Bengtsson, Tore
  • Jacobsson, Anders
  • Pamplona Gras, Reinald
  • Shabalina, Irina G.
The fatty acid elongase elongation of very long-chain fatty acids protein 2 (ELOVL2)controls the elongation of polyunsaturated fatty acids (PUFA) producing precursors for omega-3,docosahexaenoic acid (DHA), and omega-6, docosapentaenoic acid (DPAn-6)in vivo. Expectedly,Elovl2-ablation drastically reduced the DHA and DPAn-6 in liver mitochondrial membranes. Unex-pectedly, however, total PUFAs levels decreased further than could be explained by Elovl2 ablation.The lipid peroxidation process was not involved in PUFAs reduction since malondialdehyde-lysine(MDAL) and other oxidative stress biomarkers were not enhanced. The content of mitochondrialrespiratory chain proteins remained unchanged. Still, membrane remodeling was associated withthe high voltage-dependent anion channel (VDAC) and adenine nucleotide translocase 2 (ANT2),a possible reflection of the increased demand on phospholipid transport to the mitochondria. Mi-tochondrial function was impaired despite preserved content of the respiratory chain proteins andthe absence of oxidative damage. Oligomycin-insensitive oxygen consumption increased, and coeffi-cients of respiratory control were reduced by 50%. The mitochondria became very sensitive to fattyacid-induced uncoupling and permeabilization, where ANT2 is involved. Mitochondrial volume andnumber of peroxisomes increased as revealed by transmission electron microscopy. In conclusion,the results imply that endogenous DHA production is vital for the normal function of mouse livermitochondria and could be relevant not only for mice but also for human metabolism., This study was supported by grants from the Swedish Science Council (VR-NT 2017-04715and VR-MT 2019-01508). This research was also funded in part by the Spanish Ministry of Science,Innovation, and Universities (grant RTI2018-099200-B-I00), and the Generalitat of Catalonia: Agencyfor Management of University and Research Grants (2017SGR696) to R.P. This study was co-financedby FEDER funds from the European Union (“A way to build Europe”). IRB Lleida is a CERCAProgramme/Generalitat of Catalonia. Open access funding was provided by Stockholm University,Sweden.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cell Stress Induces Mislocalization of Transcription Factors with Mitochondrial Enrichment

  • Rossi, Chiara
  • Fernàndez, Anna
  • Torres Cabestany, Pascual
  • Ramírez-Núñez, Omar
  • Granado-Serrano, Ana Belén
  • Fontdevila Olivé, Laia
  • Povedano, Mònica
  • Pamplona Gras, Reinald
  • Ferrer, Isidre
  • Portero Otín, Manuel
Previous evidence links the formation of extranuclear inclusions of transcription factors, such as ERK, Jun, TDP-43, and REST, with oxidative, endoplasmic-reticulum, proteasomal, and osmotic stress. To further characterize its extranuclear location, we performed a high-content screening based on confocal microscopy and automatized image analyses of an epithelial cell culture treated with hydrogen peroxide, thapsigargin, epoxomicin, or sorbitol at different concentrations and times to recreate the stresses mentioned above. We also performed a subcellular fractionation of the brain from transgenic mice overexpressing the Q331K-mutated TARDBP, and we analyzed the REST-regulated mRNAs. The results show that these nuclear proteins exhibit a mitochondrial location, together with significant nuclear/extranuclear ratio changes, in a protein and stress-specific manner. The presence of these proteins in enriched mitochondrial fractions in vivo confirmed the results of the image analyses. TDP-43 aggregation was associated with alterations in the mRNA levels of the REST target genes involved in calcium homeostasis, apoptosis, and metabolism. In conclusion, cell stress increased the mitochondrial translocation of nuclear proteins, increasing the chance of proteostasis alterations. Furthermore, TDP-43 aggregation impacts REST target genes, disclosing an exciting interaction between these two transcription factors in neurodegenerative processes., This research was funded by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI 17–00134, PI20-0155) to M.P-O, from the Spanish Ministry ofScience, Innovation, and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department ofHealth (SLT002/16/00250) to RP. PT was a predoctoral fellow from the Ministerio de Educacion(FPU16/01446). CR and LF held predoctoral fellowships “Ajuts 2020 & 2021 de Promocióde laRecerca en Salut -8ª edició” from IRBLleida/Diputacióde Lleida. Support was also received inthe form of a Fundación Española para el Fomento de la Investigación de la Esclerosis Lateral Amiotrófica (FUNDELA] Grant, RedELA-Plataforma Investigación, and the Fundació Miquel Valls (Jack Van den Hoek donation]. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is funded by a Centres de Recerca de Catalunya (CERCA)Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Up-Regulation of Specific Bioactive Lipids in Celiac Disease

  • Martín Masot, Rafael
  • Galo-Licona, José Daniel
  • Mota Martorell, Natàlia
  • Sol, Joaquim
  • Jové Font, Mariona
  • Maldonado, José
  • Pamplona Gras, Reinald
  • Nestares, Teresa
Celiac disease (CD) is an autoimmune enteropathy linked to alterations of metabolism. Currently, limited untargeted metabolomic studies evaluating differences in the plasma metabolome of CD subjects have been documented. We engage in a metabolomic study that analyzes plasma metabolome in 17 children with CD treated with a gluten-free diet and 17 healthy control siblings in order to recognize potential changes in metabolic networks. Our data demonstrates the persistence of metabolic defects in CD subjects in spite of the dietary treatment, affecting a minor but significant fraction (around 4%, 209 out of 4893 molecular features) of the analyzed plasma metabolome. The affected molecular species are mainly, but not exclusively, lipid species with a particular affectation of steroids and derivatives (indicating an adrenal gland affectation), glycerophospholipids (to highlight phosphatidic acid), glycerolipids (with a special affectation of diacylglycerols), and fatty acyls (eicosanoids). Our findings are suggestive of an activation of the diacylglycerol-phosphatidic acid signaling pathway in CD that may potentially have detrimental effects via activation of several targets including protein kinases such as mTOR, which could be the basis of the morbidity and mortality connected with untreated CD. However, more studies are necessary to validate this idea regarding CD., This research was funded by the Regional Government of Andalusia, Excellence Research (Project No P12-AGR-2581); by the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-BI00); by the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696); and by the Department of Health (SLT002/16/00250) to R.P. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia. The study was also partially funded by the grant “Investigation grant program by the Association of Celiacs and Sensitive to Gluten of the Community of Madrid”.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

  • Dakterzada, Farida
  • Benítez, Iván
  • Targa, Adriano
  • Pujol, Montserrat
  • Carnes Vendrell, Anna
  • Jové Font, Mariona
  • Minguez Roure, Olga
  • Vaca, Rafaela
  • Sánchez de la Torre, Manuel
  • Barbé Illa, Ferran
  • Pamplona Gras, Reinald
  • Piñol Ripoll, Gerard
Background Obstructive sleep apnoea (OSA) has a high prevalence in patients with Alzheimer’s disease (AD). Both conditions have been shown to be associated with lipid dysregulation. However, the relationship between OSA severity and alterations in lipid metabolism in the brains of patients with AD has yet to be fully elucidated. In this context, we examined the cerebrospinal fluid (CSF) lipidome of patients with suspected OSA to identify potential diagnostic biomarkers and to provide insights into the pathophysiological mechanisms underlying the effect of OSA on AD. Methods The study included 91 consecutive AD patients who underwent overnight polysomnography (PSG) to diagnose severe OSA (apnoea‑hypopnea index ≥ 30/h). The next morning, CSF samples were collected and analysed by liquid chromatography coupled to mass spectrometry in an LC‑ESI‑QTOF‑MS/MS platform. Results The CSF levels of 11 lipid species were significantly different between AD patients with (N = 38) and without (N = 58) severe OSA. Five lipids (including oxidized triglyceride OxTG(57:2) and four unknown lipids) were significantly correlated with specific PSG measures of OSA severity related to sleep fragmentation and hypoxemia. Our analyses revealed a 4‑lipid signature (including oxidized ceramide OxCer(40:6) and three unknown lipids) that provided an accuracy of 0.80 (95% CI: 0.71–0.89) in the detection of severe OSA. These lipids increased the discriminative power of the STOP‑Bang questionnaire in terms of the area under the curve (AUC) from 0.61 (0.50–0.74) to 0.85 (0.71–0.93). Conclusions Our results reveal a CSF lipidomic fingerprint that allows the identification of AD patients with severe OSA. Our findings suggest that an increase in central nervous system lipoxidation may be the principal mechanism underlying the association between OSA and AD., Government of Catalonia, Department of Health (PERIS 2019 SLT008/18/00050), the Agency for the Management of University and Research Grants (2021 SGR 00761), and “Fundació La Marató TV3” (464/C/2014) to GPR. The Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades), co‑financed by FEDER funds from the European Union “A way to build Europe” (grant RTI2018‑099200‑B‑I00), the IRBLleida‑Diputació de Lleida (PIRS2021), and the Government of Catalonia: Agency for Management of University and Research Grants (2017SGR696) to RP. IRBLleida is a CERCA Program of the Government of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipidomic signature of stroke recurrence after transient ischemic attack

  • Purroy, Francisco
  • Ois Santiago, Angel Javier
  • Jové, Mariona
  • Arque, Gloria
  • Sol, Joaquim
  • Mauri Capdevila, Gerard
  • Rodríguez-Campello, Ana
  • Pamplona, Reinald
  • Portero Otín, Manuel
  • Roquer, Jaume
While TIA patients have transient symptoms, they should not be underestimated, as they could have an underlying pathology that may lead to a subsequent stroke: stroke recurrence (SR). Previously, it has been described the involvement of lipids in different vascular diseases. The aim of the current study was to perform a lipidomic analysis to identify differences in the lipidomic profile between patients with SR and patients without. Untargeted lipidomic analysis was performed in plasma samples of 460 consecutive TIA patients recruited < 24 h after the onset of symptoms. 37 (8%) patients suffered SR at 90 days. Lipidomic profiling disclosed 7 lipid species differentially expressed between groups: 5 triacylglycerides (TG), 1 diacylglyceride (DG), and 1 alkenyl-PE (plasmalogen) [specifically, TG(56:1), TG(63:0), TG(58:2), TG(50:5), TG(53:7, DG(38:5)) and PE(P-18:0/18:2)]. 6 of these 7 lipid species belonged to the glycerolipid family and a plasmalogen, pointing to bioenergetics pathways, as well as oxidative stress response. In this context, it was proposed the PE(P-18:0/18:2) as potential biomarker of SR condition.The observed changes in lipid patterns suggest pathophysiological mechanisms associated with lipid droplets metabolism and antioxidant protection that is translated to plasma level as consequence of a more intensive or high-risk ischemic condition related to SR., This study was supported by the Government of Catalonia-Agència de Gestió d'Ajuts Universitaris i de Recerca (FP: 2017SGR1628 and 2021SGR01479; RP: 2021SGR00990); Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF, "Investing in your future" and "A way to build Europe") (FP: PI17-01725, PI14/01574; M.P-O: PI 17-00134, 20-0155); the Spanish Ministry of Science, Innovation and Universities (RP: RTI2018-099200-B-I00 and PID2022-143140OB-I00); the Department of Health (RP: SLT002/16/00250); and the INVICTUS plus Research Network (Carlos III Health Institute) (FP, CT and GA: RD16-0019-0017; TS: RD16-0019-0012; AO and JR: RD16-0019-0012; AC: RD16-0019-0006. M.J. is a professor under the Serra Hunter program (Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The advanced lipoxidation end-product malondialdehyde-lysine in aging and longevity

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Pradas Barriga, Irene
  • Martín Garí, Meritxell
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Pamplona Gras, Reinald
The nonenzymatic adduction of malondialdehyde (MDA) to the protein amino groups leads to the formation of malondialdehyde-lysine (MDALys). The degree of unsaturation of biological membranes and the intracellular oxidative conditions are the main factors that modulate MDALys formation. The low concentration of this modification in the different cellular components, found in a wide diversity of tissues and animal species, is indicative of the presence of a complex network of cellular protection mechanisms that avoid its cytotoxic effects. In this review, we will focus on the chemistry of this lipoxidation-derived protein modification, the specificity of MDALys formation in proteins, the methodology used for its detection and quantification, the MDA-lipoxidized proteome, the metabolism of MDA-modified proteins, and the detrimental effects of this protein modification. We also propose that MDALys is an indicator of the rate of aging based on findings which demonstrate that (i) MDALys accumulates in tissues with age, (ii) the lower the concentration of MDALys the greater the longevity of the animal species, and (iii) its concentration is attenuated by anti-aging nutritional and pharmacological interventions, Research by the authors was supported by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (FIS grants PI13/00584 and PI14/00328), the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-BI00), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696), and Department of Health (SLT002/16/00250) to RP. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Microbiota alterations in proline metabolism impact depression

  • Mayneris Perxachs, Jordi
  • Martin, Miquel
  • Burokas, Aurelijus, 1982-
  • Escrichs, Anira
  • Deco, Gustavo
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
The microbiota-gut-brain axis has emerged as a novel target in depression, a disorder with low treatment efficacy. However, the field is dominated by underpowered studies focusing on major depression not addressing microbiome functionality, compositional nature, or confounding factors. We applied a multi-omics approach combining pre-clinical models with three human cohorts including patients with mild depression. Microbial functions and metabolites converging onto glutamate/GABA metabolism, particularly proline, were linked to depression. High proline consumption was the dietary factor with the strongest impact on depression. Whole-brain dynamics revealed rich club network disruptions associated with depression and circulating proline. Proline supplementation in mice exacerbated depression along with microbial translocation. Human microbiota transplantation induced an emotionally impaired phenotype in mice and alterations in GABA-, proline-, and extracellular matrix-related prefrontal cortex genes. RNAi-mediated knockdown of proline and GABA transporters in Drosophila and mono-association with L. plantarum, a high GABA producer, conferred protection against depression-like states. Targeting the microbiome and dietary proline may open new windows for efficient depression treatment., This work was partially supported by Instituto de Salud Carlos III (Madrid, Spain) through the research grants PI15/01934, PI18/01022, and PI21/01361 to J.M.F.-R. and PI20/01090 (co-funded by the European Regional Development Fund. “A way to make Europe”) to J.M.-P.; the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R.; the Spanish Ministry of Science, Innovation and Universities (PID2019-105969GB-I00); Generalitat Valenciana (Prometeo/2018/133), Spain; and Fondo Europeo de Desarrollo Regional (FEDER) funds to A.M. This work was also supported by the European Commission (FP7, NeuroPain #2013-602891); the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020) to R.M.; the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) to R.M.; Ministry of Science and Innovation and State Research Agency (#PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033) to R.M.; the European Regional Development Fund (project no. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and the Project ThinkGut (EFA345/19), 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra program (POCTEFA, 2014–2020). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00) and the Generalitat of Catalonia (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [SLT002/16/00250]) to R.P. M.A.-R. is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). J.M.-P. is funded by a Miguel Servet contract (CP18/00009) from the Instituto de Salud Carlos III. J.S. is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. M.J. is a professor under “Serra Hunter” program (Generalitat de Catalunya). The graphical abstract was created with BioRender.com. We would like to thank Martijn Eidhof for his help in building the stress treatment machine for Drosophila.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Effects of aging and methionine restriction on rat kidney metabolome

  • Pradas Barriga, Irene
  • Jové Font, Mariona
  • Cabré Cucó, Rosanna
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Mota Martorell, Natàlia
  • Pamplona Gras, Reinald
Methionine restriction (MetR) in animal models extends maximum longevity and seems to promote renoprotection by attenuating kidney injury. MetR has also been proven to affect several metabolic pathways including lipid metabolism. However, there is a lack of studies about the effect of MetR at old age on the kidney metabolome. In view of this, a mass spectrometry-based high-throughput metabolomic and lipidomic profiling was undertaken of renal cortex samples of three groups of male rats—An 8-month-old Adult group, a 26-month-old Aged group, and a MetR group that also comprised of 26-month-old rats but were subjected to an 80% MetR diet for 7 weeks. Additionally, markers of mitochondrial stress and protein oxidative damage were analyzed by mass spectrometry. Our results showed minor changes during aging in the renal cortex metabolome, with less than 59 differential metabolites between the Adult and Aged groups, which represents about 4% of changes in the kidney metabolome. Among the compounds identified are glycerolipids and lipid species derived from arachidonic acid metabolism. MetR at old age preferentially induces lipid changes affecting glycerophospholipids, docosanoids, and eicosanoids. No significant differences were observed between the experimental groups in the markers of mitochondrial stress and tissue protein damage. More than rejuvenation, MetR seems to induce a metabolic reprogramming, We acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia, Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to R.P. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). I.P. was supported by a University of Lleida Predoctoral Fellowship. R.C. and N.M.M. were supported by a Generalitat of Catalonia Predoctoral Fellowship. M.J. is a Serra Húnter Fellow.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The lipidome fingerprint of longevity

  • Jové Font, Mariona
  • Mota Martorell, Natàlia
  • Pradas Barriga, Irene
  • Galo-Licona, José Daniel
  • Martín Garí, Meritxell
  • Obis Monné, Èlia
  • Sol, Joaquim
  • Pamplona Gras, Reinald
Lipids were determinants in the appearance and evolution of life. Recent studies disclose the existence of a link between lipids and animal longevity. Findings from both comparative studies and genetics and nutritional interventions in invertebrates, vertebrates, and exceptionally long-lived animal species—humans included—demonstrate that both the cell membrane fatty acid profile and lipidome are a species-specific optimized evolutionary adaptation and traits associated with longevity. All these emerging observations point to lipids as a key target to study the molecular mechanisms underlying differences in longevity and suggest the existence of a lipidome profile of long life., Research by the authors was supported by the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-BI00), and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to RP. This study was co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Succination of protein thiols in human brain aging

  • Jové Font, Mariona
  • Pradas Barriga, Irene
  • Mota Martorell, Natàlia
  • Cabré Cucó, Rosanna
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Ferrer, Isidre
  • Pamplona Gras, Reinald
Human brain evolution toward complexity has been achieved with increasing energy supply as the main adaptation in brain metabolism. Energy metabolism, like other biochemical reactions in aerobic cells, is under enzymatic control and strictly regulated. Nevertheless, physiologically uncontrolled and deleterious reactions take place. It has been proposed that these reactions constitute the basic molecular mechanisms that underlie the maintenance or loss-of-function of neurons and, by extension, cerebral functions during brain aging. In this review article, we focus attention on the role of the nonenzymatic and irreversible adduction of fumarate to the protein thiols, which leads to the formation of S-(2-succino)cysteine (2SC; protein succination) in the human brain. In particular, we first offer a brief approach to the succination reaction, features related to the specificity of protein succination, methods for their detection and quantification, the bases for considering 2SC as a biomarker of mitochondrial stress, the succinated proteome, the cross-regional differences in 2SC content, and changes during brain aging, as well as the potential regulatory significance of fumarate and 2SC. We propose that 2SC defines cross-regional differences of metabolic mitochondrial stress in the human brain and that mitochondrial stress is sustained throughout the healthy adult lifespan in order to preserve neuronal function and survival., Research by the authors was supported by the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (FIS grants PI13/00584 and PI14/00328), the Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-B-I00), and the Generalitat of Catalonia, Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250) to RP. This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”). IRBLleida is a CERCA Programme/Generalitat of Catalonia. IP was supported by a University of Lleida Predoctoral Fellowship. RC and NM-M were supported by a Generalitat of Catalonia Predoctoral Fellowship. MJ is a “Serra Húnter” Fellow.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression

  • Sol, Joaquim
  • Jové Font, Mariona
  • Povedano, Mònica
  • Sproviero, William
  • Dominguez, Raul
  • Piñol Ripoll, Gerard
  • Romero Guevara, Ricardo
  • Hye, Abdul
  • Al-Chalabi, Ammar
  • Torres Cabestany, Pascual
  • Andrés Benito, Pol
  • Area Gomez, Estela
  • Pamplona Gras, Reinald
  • Ferrer, Isidre
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Portero Otín, Manuel
Since amyotrophic lateral sclerosis cases exhibit significant heterogeneity, we aim to investigate the association of lipid composition of plasma and CSF with amyotrophic lateral sclerosis diagnosis, its progression and clinical characteristics. Lipidome analyses would help to stratify patients on a molecular basis. For this reason, we have analysed the lipid composition of paired plasma and CSF samples from amyotrophic lateral sclerosis cases and age-matched non-amyotrophic lateral sclerosis individuals (controls) by comprehensive liquid chromatography coupled to mass spectrometry. The concentrations of neurofilament light chain—an index of neuronal damage—were also quantified in CSF samples and plasma. Amyotrophic lateral sclerosis versus control comparison, in a moderate stringency mode, showed that plasma from cases contains more differential lipids (n = 122 for raw P < 0.05; n = 27 for P < 0.01) than CSF (n = 17 for raw P < 0.05; n = 4 for P < 0.01), with almost no overlapping differential species, mainly characterized by an increased content of triacylglyceride species in plasma and decreased in CSF. Of note, false discovery rate correction indicated that one of the CSF lipids (monoacylglycerol 18:0) had high statistic robustness (false discovery rate-P < 0.01). Plasma lipidomes also varied significantly with the main involvement at onset (bulbar, spinal or respiratory). Notably, faster progression cases showed particular lipidome fingerprints, featured by decreased triacylclycerides and specific phospholipids in plasma, with 11 lipids with false discovery rate-P < 0.1 (n = 56 lipids in plasma for raw P < 0.01). Lipid species associated with progression rate clustered in a relatively low number of metabolic pathways, mainly triacylglyceride metabolism and glycerophospholipid and sphingolipid biosynthesis. A specific triacylglyceride (68:12), correlated with neurofilament content (r = 0.8, P < 0.008). Thus, the present findings suggest that systemic hypermetabolism—potentially sustained by increased triacylglyceride content—and CNS alterations of specific lipid pathways could be associated as modifiers of disease progression. Furthermore, these results confirm biochemical lipid heterogeneity in amyotrophic lateral sclerosis with different presentations and progression, suggesting the use of specific lipid species as potential disease classifiers., We acknowledge funding from the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI 17-00134, PI20-0155) to M.P-O; from the Spanish Ministry of Science, Innovation, and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia [Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)] to R.P. P.T. is a predoctoral fellow from the Ministerio de Educacion (FPU16/01446). Support was also received in the form of a Fundación Española para el Fomento de la Investigación de la Esclerosis Lateral Amiotrófica (FUNDELA) Grant, RedELA-Plataforma Investigación, and the Fundació Miquel Valls (Jack Van den Hoek donation). M.J. is a professor under the Serra Hunter program (Generalitat de Catalunya). Dr W.S. was funded by the Motor Neurone Disease Association (grant application Al-Chalabi/Apr15/844-791). This study has been co-financed by FEDER funds from the European Union (‘A way to build Europe’). IRBLleida is funded by a Centres de Recerca de Catalunya (CERCA) Programme/Generalitat of Catalonia.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

  • Gatius Calderó, Sònia
  • Jové Font, Mariona
  • Megino-Luque, Cristina
  • Albertí Valls, Manel
  • Yeramian Hakim, Andree
  • Bonifaci, Núria
  • Pinyol, Miquel
  • Santacana Espasa, Maria
  • Pradas Barriga, Irene
  • Llobet Navàs, David
  • Pamplona Gras, Reinald
  • Matias-Guiu, Xavier
  • Eritja Sánchez, Núria
Metabolomic profiling analysis has the potential to highlight new molecules and cellular pathways that may serve as potential therapeutic targets for disease treatment. In this study, we used an LC-MS/MS platform to define, for the first time, the specific metabolomic signature of uterine serous carcinoma (SC), a relatively rare and aggressive variant of endometrial cancer (EC) responsible for 40% of all endometrial cancer-related deaths. A metabolomic analysis of 31 ECs (20 endometrial endometrioid carcinomas (EECs) and 11 SCs) was performed. Following multivariate statistical analysis, we identified 232 statistically different metabolites among the SC and EEC patient samples. Notably, most of the metabolites identified (89.2%) were lipid species and showed lower levels in SCs when compared to EECs. In addition to lipids, we also documented metabolites belonging to amino acids and purine nucleotides (such as 2-Oxo-4-methylthiobutanoic acid, synthesised by acireductone dioxygenase 1 (ADI1) enzyme), which showed higher levels in SCs. To further investigate the role of ADI1 in SC, we analysed the expression protein levels of ADI1 in 96 ECs (67 EECs and 29 SCs), proving that the levels of ADI1 were higher in SCs compared to EECs. We also found that ADI1 mRNA levels were higher in p53 abnormal ECs compared to p53 wild type tumours. Furthermore, elevated ADI1 mRNA levels showed a statistically significant negative correlation with overall survival and progression-free survival among EEC patients. Finally, we tested the ability of ADI1 to induce migration and invasion capabilities in EC cell lines. Altogether, these results suggest that ADI1 could be a potential therapeutic target in poor-prognosis SCs and other Ecs with abnormal p53 expression., This study was funded by the Instituto de Salud Carlos III (ISCIII) through projects PI20/00502, CP19/00025, CB16/12/00231, PI16/00692, PI18/00573, PI21/00672, CP17/00063 and PI18/00795; and by the Spanish Ministry of Science, Innovation and Universities (Ministerio de Ciencia, Innovación y Universidades, RTI2018-099200-BI00), co-funded by the European Regional Development Fund (ERDF) as part of the “A way to make Europe” programme and the European Social Fund (ESF) as part of the “Investing in Your Future” programme. This study was also supported by the “Xarxa de Bancs de Tumors de Catalunya” and sponsored by “Pla Director d’Oncologia de Catalunya (XBTC)”, “IRBLleida Biobank” (B.0000682) and “Plataforma Biobancos” PT20/00021. We also thank the Generalitat of Catalonia: Agency for Management of University and Research Grants (2017SGR1368 and 2017SGR696) and the “Asociación Española Contra el Cáncer” (AECC; Grupos Estables 2018 and LABAE19004LLOB). M.J. is a Serra Húnter Fellow. N.E. (MS19/00025) and D.L-N. (MS17/00063) are recipients of a Miguel Servet research scheme (co-funded by the ESF program “Investing in Your Future”). C. M-L. holds a predoctoral fellowship from the Generalitat de Catalunya (2020FI_B2 00099) and the predoctoral fellowship “Ajuts 2021 de Promoció de la Recerca en Salut-9a edició” from IRBLleida/Diputació de Lleida. IRBLleida is a CERCA Program/Generalitat of Catalonia.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Phenotypic molecular features of long-lived animal species

  • Jové, Mariona
  • Mota Martorell, Natàlia
  • Fernàndez Bernal, Anna
  • Portero Otin, Manuel
  • Barja De Quiroga Losada, Gustavo
  • Pamplona, Reinald
One of the challenges facing science/biology today is uncovering the molecular bases that support and determine animal and human longevity. Nature, in offering a diversity of animal species that differ in longevity by more than 5 orders of magnitude, is the best ‘experimental laboratory’ to achieve this aim. Mammals, in particular, can differ by more than 200-fold in longevity. For this reason, most of the available evidence on this topic derives from comparative physiology studies. But why can human beings, for instance, reach 120 years whereas rats only last at best 4 years? How does nature change the longevity of species? Longevity is a species-specific feature resulting from an evolutionary process. Long-lived animal species, including humans, show adaptations at all levels of biological organization, from metabolites to genome, supported by signaling and regulatory networks. The structural and functional features that define a long-lived species may suggest that longevity is a programmed biological property.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prevalence and Predictors of Cerebral Microangiopathy Determined by Pulsatility Index in an Asymptomatic Population From the ILERVAS Project

  • Purroy, Francisco|||0000-0002-1808-5968
  • Sánchez, Enric|||0000-0001-7345-1601
  • Lecube, Albert|||0000-0001-9684-0183
  • Arque, Gloria|||0000-0002-8039-3726
  • Vicente-Pascual, Mikel
  • Mauri-Capdevila, Gerard
  • Torreguitart, Núria
  • Hernández García, Marta|||0000-0003-1237-298X
  • Barbé, Ferran|||0000-0002-2340-8928
  • Fernández, Elvira|||0000-0001-5236-1762
  • Pamplona, Reinald|||0000-0003-4337-6107
  • Farràs-Sallés, Cristina|||0000-0001-5956-4116
  • Mauricio, Didac|||0000-0002-2868-0250
  • Bermúdez-López, Marcelino|||0000-0002-3188-4158
Background: Little is known about the prevalence of cerebral microangiopathy (CM), which is related to cognitive impairment, in an asymptomatic population. Pulsatility index (PI) is an easily measurable parameter of cerebral vascular resistance in transcranial duplex of the middle cerebral artery (MCA) study. We aimed to determine the prevalence of CM measured by PI of MCA in low to moderate vascular risk subjects. Methods: We included 3,721 subjects between 45 and 70 years without previous history of vascular disease or diabetes mellitus and with at least one other vascular risk factor from the cross-sectional study ILERVAS (Lleida, Spain). Patients underwent transcranial duplex to determine MCA-PI. Possible CM was defined by MCA-PI.